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"There is a single light of science and to brighten it anywhere is to brighten it everywhere." 








“Why?”, and later “How?”. Those two questions are what led me to research, without doubt. I’ve asked 
them (aloud or not) every day for as long as I can remember, about practically everything. The other 
thing is being amazed by Nature. The diversity of every aspect and how it all functions as one, somehow. 
My favorite as a child were the documentaries by “le Commandant Cousteau” (the sharks!), and my 
dream was to be an oceanographer. I pursued that dream up until my first year of university, when I 
discovered biochemistry. I had already grown a liking for chemistry, and it was the only discipline that 
answered the “biological whys and hows” without going into physics. Biochemistry studies and does, 
both trying to unravel Nature’s secrets and building its own means to do so. It also uses the knowledge 
to improve human living conditions, at least in theory. I was sold, and here I am. It is at least as much 
fun as I thought it would be. 
I began this project with only general knowledge about glycosylation, having specialized in enzymology 
and bioinformatics during my studies. I knew that sugar modifications were, roughly, adding another 
level of diversity to proteins and cell surfaces, but I had greatly underestimated the scale of it and the 
consequences of that. If nothing else, I am happy that I got to learn about it. Nature is still amazing, if 
you’re wondering.  
I thought that I would spend my time doing enzymology with a little modelling on the side, especially 
looking forward to the kinetics. The latter is my one and only regret, and I fully intend to rectify that in 
the future. However, I got to do crystallization, genomics and metabolomics. I got to try to make sense 
of existing data, provide some new, and prepare for further studies. I got to try, fail, try again, fail again, 
give up and do something else. I learned so much that I would like to do it all over again, so that I could 
do everything better, and try a thousand other things. 
I cannot talk about this experience without mentioning Tromsø. It is such a special place that it is an 
experience in itself. The arctic climate of course, but also living in a post-card every hour of every day. 
The people, the mix of local and international that creates such a special atmosphere. There is everything 
and everyone, in the middle of nowhere. And the whales, next best thing to sharks. 
Doing a PhD was just fantastic. Fun in a brain-racking, nerve wracking, incredibly fulfilling way. An 
exercise in perseverance. A study of the response to environmental stress. But most of all, an 
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Nonulosonic acids (NulOs) are sugars expressed on the surface of bacterial cells as well as vertebrates 
and are involved in a multitude of physiological and pathogenic processes. Their biosynthesis is directed 
by gene clusters that vary in both gene content and organization, leading to a diverse family of 
compounds. The exploration of this diversity is relatively recent, helped by the amount of genetic data 
generated by new technologies. It is however limited by the availability of the compounds themselves 
and the means to produce them. The presented work describes, for the first part, the study of NulO 
biosynthesis gene clusters in the fish pathogens A. salmonicida, A. wodanis and M. viscosa in relation to 
the type of NulO they produce. The key enzyme of the biosynthesis, NeuB, is considered in terms of 
amino-acid sequence, active-site geometry, and substrate specificity. The second part deals with the 
bioprospecting of N-acetyl-2-glucosamine epimerases (AGEs) for the in vitro synthesis of N-
acetylneuraminic acid, the most abundant NulO in nature. Two isolates of the cyanobacterium Nostoc 
sp. (KVJ10 and KV20) were targeted. Nostoc sp. KVJ20 was sequenced, and the AGEs from both strains 
(nAGE10 and nAGE20) were cloned, expressed, and purified. The crystal structure of nAGE10 was 
solved, revealing a new (and most likely biologically relevant) dimeric organization of AGEs. Together, 
these studies participate in the monumental task of understanding the determinants of NulO diversity 
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Living cells are composed of four major classes of molecules, each providing a level of information and 
regulation which direct cell structure and function. DNA contains the information necessary to 
synthetize all other cell components, and proteins, which result from its interpretation, form the bulk of 
the cell structure and effector machinery. The two remaining components, lipids and carbohydrates, 
possess a greater diversity both in structure and function, the latter being the most diverse of all. The 
carbohydrate components of cells, referred to as glycans, include both mono-, oligo-, and 
polysaccharides, which can be either free or attached to proteins (glycoproteins) or lipids (glycolipids) 
[1]. 
Bacterial glycans are a major component of all elements of the bacterial cell wall, from the inner 
membrane to the lipopolysaccharide of Gram-negative bacteria, but also of capsules, pili, flagella and 
biofilms [2]. The structures that they form enable cells to, for example, resist various osmotic conditions, 
or prevent desiccation. They also give the cell wall its negative charge. In addition to their more 
structural functions, their location at the periphery of the cell places them in an ideal position for 
participating in the many interactions that take place with the immediate surroundings, be it another 
cell, a host, or the outside environment. In pathogenic bacteria, cell wall glycans house many virulence 
factors such as lipid A, O-, F-, K- and H-antigens, and nonulosonic acids, which are the subject of this 
thesis. 
 
1.1 The sugars of the bacterial cell surface 
Prokaryotic and eukaryotic cells are delimited by a cytoplasmic membrane coated by different 
structures, all containing various glycans amongst which nonulosonic acids can be found. This section 





Figure 1. Bacterial cell surface. A: Schemativ representation of a bacterial cell. Adapted from the image by Ali Zifan, 
distributed under the CC BY-SA 4.0 license. B: Cell wall of typical gram-positive and gram-negative bacteria. Adapted from 
[3]. 
 
1.1.1 Bacterial membranes and lipopolysaccharide 
Every cell is separated from the environment by a semi-permeable barrier composed of one or several 
layers (see Figure 1). The innermost layer is the cytoplasmic membrane (CM), also known as the plasma 
membrane, which is common to all cells. It surrounds the cytoplasm and serves as anchor to the 
cytoskeleton as well as the components that form the outer layers coating it (see Figure 1B). In gram-
negative bacteria and mycobacteria, a second membrane is present, called the outer membrane (OM) 
[2]. In this case, the CM is often referred to as the inner membrane, which has a different composition 
than the single membrane of gram-positive bacteria. 
The CM is composed of lipids and proteins, some of which are glycosylated. Phospholipids are the main 
lipid component, but various phosphate-free lipids are also present, and membrane composition varies 
across species, even within the same bacteria type [4]. Sterols, which are ubiquitous to eukaryotic 
membranes, are seldom found in prokaryotic ones. The proteins of the CM vary according to whether 




As mentioned earlier, gram-negative bacteria and mycobacteria have an outer membrane. It is separated 
from the cytoplasmic membrane by a thin layer of peptidoglycan with periplasmic space on either side 
of it (see next section). It is formed by an asymmetric lipid bilayer composed of phospholipids on the 
inner leaflet and lipid A on the outer one. 
The inner leaflet of the outer membrane faces the periplasm and is linked to the peptidoglycan by 
lipoproteins [5]. The outer leaflet is characterized by its main component, lipid A, which carries various 
glycan chains a thus forms the bacterial lipopolysaccharide (LPS). The glycan chains are usually strain 
specific, and the terminal part of the LPS is referred to as O-antigen due to its antigenic properties. 
Lipooligosaccharides (LOS) lack the O-antigen, consisting only of lipid A and the core oligosaccharide. 
The sterol-like lipids hopanoids interact with lipid A and play a role in ordering the membrane [6]. 
The glycans associated to the plasma and outer membranes are various and depend on the type of 
membrane considered. The CM of single membrane prokaryotes carries numerous glycoconjugates, but 
they are mostly associated with the different extracellular structures composing their cell surfaces and 
will be treated in the corresponding sections [2]. For gram-negative bacteria, glycoconjugates seems to 
absent from the CM [7]. The glycans from the OM are mainly associated with the LPS, although some are, 
as for the CM of gram-positive bacteria, corresponding to other structures [2]. Nonulosonic acid residues 
can be found as terminal residues in the LPS of numerous bacteria. 
 
1.1.2 Peptidoglycan 
The cell wall of bacteria contains a layer of peptidoglycan, also known as murein, that differs according 
to their type [8]. As mentioned earlier, gram-negative bacteria have a thin peptidoglycan layer between 
to membranes while gram-positive bacteria have a thicker peptidoglycan outside their single, plasma 
membrane (see Figure 1B). This difference is the determinant between the “Gram” classification, which 
is based on the results obtained by Gram staining [9]. The peptidoglycan is stained with crystal violet 
dye and subsequently partially decolorized using alcohol or acetone: thin peptidoglycans are 
decolorized first, thus distinguishing between the two cell wall structures. It is to be noted that some 
bacteria, such as mycoplasma, stain negative on the Gram test even though they only have one 
membrane, because they lack a peptidoglycan layer. 
The peptidoglycan is organized in a mesh and consists in linear sugar chains crosslinked by interacting 
oligopeptide chains. Each chain is a polymer of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc), with the oligopeptide attached to the latter. The composition of the oligopeptide and the 
length of glycan chains vary across species [10]. In gram-positive bacteria, the peptidoglycan also 




1.1.3 Glycocalyx and S-layer 
The glycocalyx often refers to the coating found on the apical surface of epithelial cells of animals, but 
also encompasses the bacterial capsule and slime layer. The main difference between the two is their 
degree of structure and anchorage to the underlying cell wall structures, with the capsule the “tighter” 
of the two. The glycans that compose them are different, but both capsular and slime layer 
polysaccharides, the latter called exopolysaccharides, show a high degree of diversity. Capsular 
polysaccharides from pathogenic bacteria are often designated as the K-antigen. Nonulosonic acids are 
often found in capsules, of which they can be the main component. 
The S-layer is distinct from the slime layer: it is a crystalline, monomolecular layer of proteins or 
glycoproteins, which find anchor in either the peptidoglycan (and teichoic acids) or the LPS [11]. It is 
usually, when present, the outermost layer of the bacterial cell surface, and can also contain nonulosonic 
acids. 
 
1.1.4 Pili and flagella 
Bacterial pili and flagella are protein appendages that protrude from the bacterial cell, as shown in 
Figure 1A. The term fimbriae is often used to designate pili that do not participate in bacterial 
conjugation, which are also categorized as F-antigens. In a similar manner, flagella, or more precisely 
the flagellins that composes them, are designated as H-antigens. 
Flagella are known as the surface component conferring bacterial motility, although they perform other 
functions [12]. They are anchored in the CM by their basal bodies, which extends to either the OM or the 
peptidoglycan layer (gram-negative/positive bacteria). The filament portion is a polymer of flagellin 
that is linked to the basal body by a hook region, and the glycosylated part of the flagellum [13].   
In contrast to flagella which share a common structure, there are several types of pili, which reflects the 
different functions they fullfill [14]. Theie filaments can however be described as polymers of pilin units, 
with pilin representing a class of proteins. As for flagellin, pilins can be glycosylated, and nonulosonic 





1.2 Structure of bacterial nonulosonic acids 
Nonulosonic acids (NulOs) are ketoaldonic acids, meaning that they contain both a carboxylic acid and 
a ketone group [15]. The latter is carried by the second carbon on the sugar chain, and thus ulosonic 
acids are also α-keto acids. The “non-” prefix indicates that they have a backbone formed by nine carbon 
atoms. Their closed structure, for which an example is presented in Figure 2,  is that of a pyranose 
(formed by the carbons C2 to C6) carrying a glycerol chain (at C6). NulOs contain at least 6 asymmetric 
centers (C2, and C4-C8) which are used to determine their absolute configuration. The center at C2 
distinguishes between the α and β isomers, while the C4-C7 stretch and C8 are compared to hexoses and 
glycerol, respectively. For neuraminic acid (Neu, see Figure 2), also known as sialic acid and the most 
studied of NulOs, its absolute configuration is (α/β)-D-glycero-D-galacto. In addition to the closed 
structure, it has been shown that several acyclic forms are present in solution [16]. 
 
 
Figure 2. Structure and configuration of N-acetylneuraminic acid (Neu). A: Structure. The nine carbons forming the 
Neu backbone are numbered and represented by black spheres and linked by white bonds. The functional groups area 
(C1-C2) and the glycerol chain (C7-C9) are indicated by grey rectangles, the pyranose ring by a black circle. The 
substituents carried by Neu are indicated by pink bonds. B: Superposition of D-glycerol and D-galactose onto the Neu 
backbone (grey). Neu carries its substituents in a manner adopting a D-glycero-D-galacto configuration. For each molecule, 





The varying nature and orientation of substituents on both the pyranose ring and the glycerol chain is 
responsible for the large diversity of this group of compounds. While established classification exists, 
bacterial NulOs can be grouped in three main families, as presented in Figure 3. The discrimination is 
based on the type of gene cluster that govern their biosynthesis, which will be presented in the next 
section. The first family is composed of Neu related compounds, designated as 3,5-dideoxy-D-glycero-
D-galacto-non-2-ulosonic acids. Its representative member, N-acetylneuraminic acid (Neu5Ac), carries 
an N-acetyl group at C5, in equatorial position. The two other families consist of 3,5,7,9-tetradeoxy-non-
2-ulosonic acids, which are differentiated by their absolute configurations. Pseudaminic acids (Pse) 
have the L-glycero-L-manno configuration, while legionaminic acids (Leg) are more diverse. The family 
takes its name from its representative compound, legionaminic acid, which has the D-glycero-D-galacto 
configuration seen for Neu, but four other isomers have been identified (Figure 3B) [17-21]. Recently, a 
new isomer most likely having the D-glycero-L-gluco configuration was identified and designated as 
fusaminic acid (Fus, see Figure 3A), but its biosynthesis pathway has not been investigated yet [22]. 
 
 
Figure 3. Structure of known NulOs. The common, nine-carbon backbone of NulOs is represented with white bonds, 
and the carbons are numbered. The absolute configuration of each isomer is indicated in either gray or green depending 
on the concerned chiral centers, which are marked by disks of the corresponding color. A: The three main NulOs families, 
according to their synthesis pathways, and the newly identified fusaminic acid (Fus). Neuraminic acid (Neu) is represented 
carrying an N-acetyl group in C5 (Neu5Ac), since it is the most commonly found species. Legionaminic (Leg), pseudaminic 
(Pse) and Fus carry N-linked groups in C5 and C7, which were omitted for clarity leaving only the nitrogen atom. B: Isomers 
from the legionaminic acid synthesis pathway presenting different absolute configurations. As for Leg, N-linked groups 
carried at the C5 and C7 positions are represented by the nitrogen atom only. The orange background serves to highlight 




These families represent above 40 different compounds that have been so far characterized in different 
bacteria, for which an overview (as of the end of 2018) is presented in Table 1. Their diversity lies in the 
variety of substituents that can decorate C5, C7, and C8, but also C9 and C4. N-acetylation at C5 and/or 
C7 is the most common form for both Neu and tetradeoxy- NulOs, followed by the substitution of one of 
the acetyl groups by an acetamide and the presence of O-acetylation at C8. However, a relatively small 
set of bacteria has been investigated so far compared to the range of species that might be producing 
NulOs, and the most widespread modifications might be different [23]. 
 
Table 1. Structurally identified bacterial NulOs 
Monosaccharide Organism Reference(s) 
Neu5Ac1,2 Escherichia coli  [24-26]  
 
Neisseria meningitidis  [27, 28] 
 
Hafnia alvei  [29] 
 
Campylobacter jejuni   [30-35] 
 
Aliivibrio salmonicida  [36] 
 
Moritella viscosa  [37] 
 
Rhizobium meliloti  [38] 
 Fusobacterium nucleatum [39] 
Neu5Ac7(8)OAc Neisseria meningitidis  [27] 
Neu5Ac7(9)OAc Salmonella enterica [40] 
 
Aliivibrio salmonicida  [36] 
 
Moritella viscosa  [37] 
Neu5Ac9OAc Rhizobium meliloti  [38] 
Neu5Ac7OAc8OAc Neisseria meningitidis  [27] 
Neu5Ac7Ac9Ac Escherichia coli  [41] 
Pse5Ac7Ac Escherichia coli  [42] 
 
Campylobacter jejuni  [34, 35, 43, 44] 
 
Campylobacter coli  [43, 45] 
 
Proteus vulgaris  [46] 
 
Helicobacter pylori  [44, 47] 
 
Pseudoalteromonas atlantica  [48] 
 
Rhizobium sp.  [49] 
 
Cellulophaga fucicola  [50] 
 
Piscirickettsia salmonis  [51] 
 
Acinetobacter baumannii [52, 53] 
Pse5Ac7Ac9Ac Aeromonas caviae  [44] 





Shigella boydii  [54, 55] 
 
Sinorhizobium fredii  [56] 
Pse5Ac7Hb4 Kribella spp.  [57, 58] 
Pse5Ac7Dhb1,4 Actinoplanes utahensis [59] 
Pse5Ac7Fm1 Pseudomonas aeruginosa  [60, 61] 
 
Pseudoalteromonas distincta  [62] 
Pse7Fm Pseudomonas aeruginosa [63] 
Pse5Hb7Fm Pseudomonas aeruginosa  [54, 63] 
Pse5Am7Ac Vibrio cholerae  [64] 
 
Campylobacter jejuni  [43, 44] 
Pse5Ac7Am Campylobacter jejuni  [34, 35] 
Pse5Ac7Gra1 Vibrio vulnificus  [65] 
Pse5Am7Gra Tannerella forsythia  [66]5 
Pse5Gra7Gra Campylobacter jejuni  [43]5 
Pse5Ac7Ac8OAc Campylobacter jejuni  [44] 
Pse5Am7Ac8GlnAc1 Campylobacter jejuni  [44] 
Pse5Ac7,9O(S-Pyr) 1 Pseudomonas glareae  [67] 
Pse5Gra(OMe)27Am1 Campylobacter jejuni   [35] 
Pse5Gra(OMe)27Ac Campylobacter jejuni   [35] 
Leg5Ac7Ac Campylobacter jejuni   [35] 
 
Vibrio alginolyticus  [19] 
 
Pseudomonas fluorescens  [68]3 
 
Acinetobacter baumanii  [69]3 
 
Vibrio parahaemolyticus  [70] 
Leg5Am7Ac Campylobacter jejuni   [35] 
 
Campylobacter coli  [45] 
 
Pseudomonas fluorescens  [68]3 
 
Aliivibrio salmonicida  [71, 72]3 
Leg5Hb7Ac Acinetobacter baumanii  [69]3 
Leg5Ac7AcAla1 Vibrio parahaemolyticus  [70] 
 
Vibrio vulnificus  [73] 
Leg5Ac7Ala Escherichia coli  [74] 
Leg5AmMe7Ac Campylobacter jejuni   [35] 
 
Campylobacter coli  [45] 
Leg5GluMe7Ac1 Clostridium botulinum  [75] 
Leg5Am7Ac8OAc Legionella pneumophilia  [76]3 
 
Pseudomonas fluorescens  [68]3 
4eLeg5Ac7Ac Shewanella japonica  [77] 




4eLeg5Am7Ac Legionella pneumophila  [78] 
4eLeg5Am7Ac8OAc Legionella pneumophila  [78] 
8eLeg5Ac7Ac Pseudomonas aeruginosa  [17]3 
 
Escherichia coli  [79-81] 
 
Providencia stuartii  [82] 
 
Acinetobacter baumanii  [83] 
8eLeg5Am7Ac Morganella morganii  [84] 
8eLeg5Ac7Am8OAc Shewanella putrefaciens  [85] 
8eLeg5Hb7Ac Salmonella arizonae  [86]3 
 
Yersinia ruckerii  [87]3 
Aci5Ac7Ac Acinetobacter baumanii  [20] 
8eAci5Ac7Ac Acinetobacter baumanii  [21] 
Fus5Ac7Ac Fusobacterium nucleatum [22] 
1 Ac=acetyl, Am= acetimidoyl, Fm=formyl, Hb=hydroxybutyryl, Dhb=dihydroxybutyryl, GlnAc=N-
acetylglucosamine, Me=methyl, Gra=glyceroyl, S-Pyr=(S)-1-carboxyethylidene, Ala=alanyl, 
Glu=glutamyl 
2 Unless mentioned otherwise, the groups are N-linked (i.e. Neu5Ac represents Neu5NAc, and 
Leg5AmMeAc represents Leg5NAmNMe7NAc) 
3 The ultimate configuration was determined by Tsvetkov et al., using GLC-MS and NMR on 
synthetized compounds [19]. The data was compared to that of natural compounds previously 
published. 
4 derivate with additional modifications at C4 
5 name corrected by Friedrich et al. [88] . 
 
 
1.3 nab gene clusters and NulO biosynthesis 
De novo NulO biosynthesis is directed by nab gene clusters (for nonulosonic acid biosynthesis) along 
three different pathways leading to neuraminic, legionaminic and pseudaminic acids, respectively (see 
Figure 3). Acinetaminic acids (Aci) are synthetized by a set of additional genes affixed to the Leg-
pathway cluster, and the gene cluster responsible for the synthesis of Fus has not been investigated yet 
[20]. Every nab cluster contains homologous genes that are responsible for the main biosynthesis steps 
[23]. Amongst them, the NeuB (NAB-2) homologs catalyze the critical reaction in NulO biosynthesis, the 
condensation of a hexosamine precursor with phosphoenolpyruvate (PEP) to form the corresponding 
α-ketoacid [89-91]. NeuB is the only NAB protein that is conserved across all three pathways and has 
been used for investigating the evolutionary history of NulOs [23]. 
A major hurdle in the study of the genes and enzymes that participate in NulO biosynthesis is their 
denominations. Nab gene clusters have been identified as part of other loci such as capsule biosynthesis, 




result, each enzyme has multiple names according to which organism and/or pathway it belongs to, as 
well as its similarity to other enzymes of related function. Gene names tend to be different from the 
enzyme names, when they are annotated at all. An overview of the main NAB enzymes (NAB1-3) is given 
in Table 2. 
 
Table 2. Nomenclature of main NAB enzymes 
Pathway description EC number Names 
Neu UDP-N-acetylglucosamine 2-epimerase 3.2.1.183 NeuC, NeuC1, NAB3 
 N-acetylneuraminate synthase 2.5.1.56 NeuB, NeuB1, NAB2 
 N-acetylneuraminate cytidylyltransferase  2.7.7.43 NeuA, NeuA1, NAB1 
Leg hydrolyzing UDP-N,N’-diacetylbacillosamine 2-
epimerase 
3.2.1.184 NeuC, NeuC2, NAB3, PtmD, LegG 
 N,N’-diacetyllegionaminate synthase 2.5.1.101 NeuB, NeuB2, NAB2, PtmC, LegI 
 CMP-N,N’-diacetyllegionaminic acid synthase 2.7.7.82 NeuA, NeuA2, NAB1, PtmB, LegF 
Pse pseudaminic acid synthase 2.5.1.97 NeuB, NeuB3, NAB2, PseI 
 pseudaminic acid cytidylyltransferase 2.7.7.81 NeuA, NeuA3, NAB3, PseF 
 
 
1.3.1 Neu pathway 
The nab gene cluster directing the synthesis of bacterial Neu products was first identified in Escherichia 
coli and Neisseria meningitidis serogroup B, as a part of their capsule biosynthetic region which is 
presented in Figure 4 [92, 93]. The neuA-C homologs (named siaA-C or cssA-C  in N. meningitidis) encode 
the three core NAB enzymes NeuA, NeuB and NeuC, leading to the synthesis of CMP-Neu5Ac [94-97]. 
Other organisms contain an additional gene coding for an O-acetyltransferase (NeuD family or non-
homologous proteins) responsible for diacetylated Neu products [98, 99]. The only other known 
modification of Neu is a tri-acetylated product that was identified in one strain of E. coli which genome 
has not been released [41]. 
The Neu biosynthesis pathway leads to derivatives of CMP-Neu5Ac from the precursor UDP-N-
acetylglucosamine (UDP-GlcNAc, see Figure 4). There seems to be two alternatives depending on 
whether the coding sequence for the NeuD O-acetyltransferase homolog is present. Without NeuD, the 
synthesis of CMP-Neu5Ac is performed in three steps: first the epimerization of UDP-GlcNAc to N-
acetylmannosamine (ManNAc) by NeuC, then the condensation of ManNAc and phosphoenolpyruvate 
(PEP) to Neu5Ac by NeuB, and last the activation of Neu5Ac by NeuA, leading to CMP-Neu5Ac. 




to happen before activation, and may be the first step in Neu biosynthesis [100, 101]. They also possess 
a bi-functional NeuA with an O-acetyl-esterase activity [102]. 
 
 
Figure 4. Alternative Neu biosynthesis pathways and biosynthesis clusters. A: Capsule synthesis clusters in N. 
meningitidis MC58 (genome sequence accession number NC_003112.2) and E. coli IAI39 (NC_011750.1). They contain 
genes for the synthesis (colored according to the activity of protein products) of Neu, its transfer onto glycoproteins 
(siaD/neuS), and its polymerization in the case of E. coli (neuE). The accession numbers for the protein sequences coded 
by the first and last genes of each nab cluster are indicated below their respective locations. B: Biosynthesis pathways of 
Neu5Ac and Neu5Ac7Ac. Activated neuraminic acid (CMP-Neu) is biosynthesized from UDP-N-acetylglucosamine (UDP-
GlcNAc) along two alternate routes, producing either mono- or di-acetylated Neu. For organisms without the neuD gene, 
UDP-GlcNAc is directly epimerized to N-acetylmannosamine (ManNAc) by the UDP-GlcNAc-2-epimerase NeuC and 
homologous proteins. Organisms with NeuD first synthetize O-acetylated-GlcNAc which then epimerized by NeuB to form 
O-acetylated-ManNAc. The ManNAc-based compounds are then condensed with phosphoenolpyruvate (PEP) by the 
Neuraminic acid synthase NeuB to form neuraminic acids, which are activated by the CMP-Neu synthetase NeuA. In the 







The enzymes of the Neu pathway have been characterized in several species, and the NeuA and NeuB 
crystal structures from N. meningitidis are available [103, 104]. NeuB is the most studied enzyme of all 
the NAB pathways and has been characterized in the most organisms [36, 37, 94, 105-109]. It is known 
as N-acetylneuraminate synthase and is classified as a transferase (EC 2.5.1.56). An inhibitor has 
recently been synthetized [110]. The UDP-N-acetylglucosamine 2-epimerase NeuC is a glycosidase (EC 
3.2.1.183) which hydrolyses UDP-GlcNAc to free ManNAc, not to be confused with its “non-hydrolyzing” 
counterpart (isomerase, EC 5.1.3.4) producing UDP-ManNAc [95, 111, 112]. NeuA, also known as N-
acetylneuraminate synthetase or cytidylyltransferase, is a nucleotidyltransferase (EC 2.7.7.43) 
responsible for the activation of Neu5Ac by attaching a CMP group on the oxygen carried by C2 [113, 
114]. The O-acetyl-esterase domain (enzyme activity corresponding to EC 3.1.1.53) of the bifunctional 
enzymes is thought to regulate the O-acetylation level of capsular glycans [102]. As for the other 
enzymes in the pathway, they have been characterized in several bacterial organisms [113, 115-120]. 
 
1.3.2 Leg pathway 
Legionaminic acid and its derivates can be synthetized from either UDP- or GDP-GlcNAc, but the 
pathway using GDP-linked intermediates seems to be the biologically relevant one [121, 122]. 
Biosynthesis from UDP-GlcNAc goes via the synthesis of UDP-N,N′-diacetylbacillosamine (UDP-
Bac2Ac4Ac), which is known as a component of bacterial glycoproteins [123]. The genes responsible for 
this part are the pglD-F homologs, which code for an acetyltransferase (PglD), an aminotransferase 
(PglE), and a dehydratase (PglF), respectively. PglF is responsible for the removal of the -OH group at 
C6 and the oxidation of the -OH at C4 of UDP-GlcNAc. The C4 ketone is replaced by an amino group via 
the action of PglE, and an acetyl is attached to it by PglD [124].  The pathway employing GDP-linked 
intermediates, presented in Figure 5, proceeds in a similar fashion using a different set of 
dehydratase/aminotransferase/acetyltransferase [122]. They are coded by the legB, legC and legH 
genes, respectively. In both cases, the resulting compound is processed by a hydrolyzing homolog of the 
NeuC epimerase to give 2,4-diacetamido-2,4,6-trideoxy-D-mannopyranose which is then condensed and 






Figure 5. Legionaminic acid biosynthesis pathway from GDP-N-acetylglucosamine in C. jejuni. A: Leg biosynthesis 
cluster [125, 126]. The transferase identified as LegH (coded by Cj1298) during pathway elucidation is not coded in the 
vicinity of the cluster, which contains several putative transferase sequences that have not been investigated (genes 
Cj1321-Cj1325). B: Leg biosynthesis from GDP-N-acetylglucosamine (GlcNAc). The dehydratase LegB, aminotransferase 
LegC and N-acetyltransferase LegH (or another transferase within the cluster) successively modify GDP-GlcNAc, replacing 
the OH group in C4 by an N-acetyl group. The glucosamine derivate is then epimerized by the NeuC homolog LegG to 
2,4-di-N-acetyl-6-deoxy-mannosamine, which is condensed with PEP by the NeuB homolog LegI and thereafter activated 
by the NeuA homolog LegF (also known as PtmB). Adapted from [122]. 
Both LegB and PglF are NDP-N-glucosamine 4,6-dehydratases (EC 4.2.1.135 for PglF) characterized in 
Campylobacter jejuni, coded by the non-homologous Cj1319 and Cj1120c genes, respectively [122, 124, 
127]. The crystal structure of the latter has recently been published [128]. In a similar manner, the 
aminotransferases LegC and PglE are non-homologous enzymes. PglE is a UDP-N-acetylbacillosamine 
transaminase (EC 2.6.1.34) for which the crystal structure is available, and LegC a pyridoxal-phosphate 
(PLP) -dependent GDP-4-amino-4,6-dideoxy-α-D-N-acetylglucosamine aminotransferase [129, 130]. 
PglD is a UDP-N-acetylbacillosamine N-acetyltransferase (EC 2.3.1.203), while LegH is reported as a 
GDP-4-amino-4,6-dideoxy-α-D-N-acetylglucosamine N-acetyltransferase. The crystal structure of PglD 
is available [131]. The resulting compound is NDP-2,4-diacetamido-2,4,6-trideoxy-α-D-glucopyranose 
(or NDP-N,N’-diacetylbacillosamine). As mentioned earlier, the second part of the pathway is carried out 
by Neu homologs [121, 122]. They are all known by several names. The NeuC homolog (or NAB3, NeuC2, 
PtmD, and LegG) is categorized as a hydrolyzing UDP-N,N’-diacetylbacillosamine 2-epimerase (EC 
3.2.1.184). The NeuB homolog is the N,N’-diacetyllegionaminate synthase (EC 2.5.1.101), also known as 
NAB2, NeuB2, PtmC, or LegI. At last, the NeuA homolog (NAB1, NeuA2, PtmB, LegF) is the CMP-N,N’-




While bacterial Neu variants that have been identified so far only differ by their degree of O-acetylation, 
Leg compounds are a much more diverse family (see Table 1). For most of the Leg derivates, identified 
as a part of the structural characterization of bacterial surface elements, genomic information has not 
been released and the manner of their biosynthesis remains unclear. The biosynthesis clusters have 
however been located for a few of them, which are presented in Figure 6. They seem to be composed of 
a set of six core genes, with the three Neu homologs and the dehydratase/aminotransferase pair 
responsible for the first steps of the synthesis. The last common gene does not correspond to the 
acetyltransferase LegH that was characterized for the pathway in C. jejuni, but codes for (putative) 
homologs of the NTP-transferase PtmE (colored dark green in Figure 6), which catalyzes the synthesis 
of GDP-GlcNAc [122]. The sequence coding for the aforementioned acetyltransferase can be replaced by 
other kinds of acyltransferases, which lead to different substituents at the C7 position of Leg. 
 
Figure 6. Legionaminic acid biosynthesis clusters producing Leg derivates. For each strain, the accession number 
for its genomic sequence is indicated under its name. The genes of each cluster are labelled as they are in public databases 
and colored according to (putative) function as indicated by the legend on the right. Locus tags are given for the first and 
last gene of clusters where no gene names were assigned. Coding sequences responsible for extra modification of Leg 
and the corresponding NulO structure are indicated by black arrows. A. salmonicida LFI1238 [71, 72, 132, 133]. E. coli 
GU220361 [74]. V. vulnificus CMCP6 [73]. A. baumanii LAC-4 [83, 134]. A. baumanii D36 [20, 135]. A. baumanii SGH 
0703 [21]. 
 The Leg biosynthesis cluster from Aliivibrio salmonicida LFI1238 has not been studied yet, but its 




NeuD (in yellow in Figure 6), as well as a putative N-acetyl amidotransferase (locus VSAL_RS01560, in 
orange), and is known to produce Leg5Am7Ac [19, 71, 72]. 
A pathway has been proposed for the synthesis of Leg5Ac7Ala in E. coli O161, involving the putative 
alanyl transferase coded by lea3 (shown in yellow)[74]. The cluster also contains an unknown sequence 
designated as the PLP-dependent transferase weiE, which may be involved in the synthesis of amino 
sugars [136]. Whether this sequence is essential to the synthesis of amino derivatives of Leg has not 
been investigated. The cluster from Vibrio vulnificus, which produces Leg5Ac7AcAla, contains a similar 
sequence (VV1_RS03905, referred to as nab4 by the authors) as well as an additional putative N-
acetyltransferase (VV1_RS03885, nab5) with an acetyltransf_3 domain (pfam13302) thought to add the 
extra acetyl group on the alanyl fragment [73]. 
Pathways for the synthesis of 8eLeg5Ac7Ac and Aci5Ac7Ac have also been proposed [20]. They involve 
the dehydrogenation of CMP-Leg5Ac7Ac by the MviM-like dehydrogenases ElaA (coded by 
RR41_RS18605, elaA, shown in light brown in Figure 6) and AciB, leading to compounds carrying a 
ketone group at C8 for 8eLeg and a double bond between C7 and C8 for Aci. Reduction of the ketone by 
the short-chain reductase ElaC (RR41_RS18595, elaC, colored light purple) gives 8eLeg5Ac7Ac. For Aci, 
it is proposed that AciB contains a reductase domain upon which action the D-glycero-L-altro isomer of 
Leg is formed, that is 8eAci5Ac7Ac. This seems a little particular when considering that Acinetobacter 
baumanii SGH 0703, which produces 8eAci5Ac7Ac, has a set of genes that does not include aciB, but 
another SDR coded by aciE as well as the two remaining homologs of the aci genes, aciC and aciD [21]. 





1.3.3 Pse pathway 
The Pse biosynthesis pathway, presented in Figure 7, was determined in Helicobacter pylori and C. jejuni 
and follows a route similar to that of the Leg pathway [137]. It uses UDP-GlcNAc as starting block and 
involves a set of dehydratase/aminotransferase/acetyltransferase leading to the synthesis of the Pse 
precursor (UDP-2,4-diacetamido-2,4,6-trideoxy-β-L-altropyranose). The first enzyme of the pathway, 
PseB, catalyzes the 4,6-dehydratation as well as C5 epimerization of UDP-GlcNAc. The ketone in C4 is 
then replaced by an amino group as in the Leg pathway, but with a different (axial) orientation. The 
reaction, performed by the aminotransferase PseC, is followed by N-acetylation at this position 
catalyzed by the PseH N-acetyltransferase. The Pse pathway does not involve epimerization by the NeuC 
homolog, which coding sequence is replaced by that of the hydrolase PseG within the cluster. PseG 
removes the UDP group from the Pse precursor that is then processed by the NeuB and NeuA homologs 
to give activated Pse. 
 
 
Figure 7. Pseudaminic acid biosynthesis pathway in C. jejuni NCTC 11168. A: Pse biosynthetic genes within the C. 
jejuni genome [125, 126]. Genes for which no names have been assigned in the deposited sequence are indicated the first 
and last loci of the corresponding region. Genes involved in the biosynthesis of Pse are colored according to their function. 
B: Pse biosynthesis from UDP-N-acetylglucosamine (UDP-GlcNAc). The dehydratase PseB, aminotransferase PseC, N-
acetyltransferase PseH and hydrolase PseH are responsible for the synthesis of the Pse precursor, 2,4-diacetamido-2,4,6-
trideoxy-β-L-altropyranose from UDP-GlcNAc. The precursor is condensed with PEP by the NeuB homolog PseI, which is 
then activated by the NeuA homolog PseF, leading to CMP-Pse5Ac7Ac. The activated NulO can be modified by the 





As mentioned earlier, the enzymes responsible for the synthesis of the Pse precursor belong to the 
dehydratase, aminotransferase, acetyltransferase families. While the Leg pathway also involves such 
enzymes in the same order, they are not homologs [127]. For example, PseB (or FlaA1) is a 
configuration-inverting UDP-N-acetylglucosamine 4,6-dehydratase (EC 4.2.1.115) where LegB is 
configuration retaining in addition to accepting GDP-linked substrates [127, 138, 139]. PseC is a UDP-4-
amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine transaminase (EC 2.6.1.92), and PseH (or FlmH, FlaG1) 
a UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase (EC 2.3.1.202) [127, 137]. 
The crystal structures for all three enzymes are available [140-143]. PseG is a UDP-2,4-diacetamido-
2,4,6-trideoxy-beta-L-altropyranose hydrolase (EC 3.6.1.57), also with an available structure [144, 145]. 
The pseudaminic acid synthase PseI (NeuB3, EC 2.5.1.97) and the cytidylyltransferase PseF (NeuA3, EC 
2.7.7.81) have been characterized [91, 137]. 
Identified Pse modifications are even more diverse than what has been found for Leg compounds, with 
substituents such as formyl or glyceroyl groups (see Table 1). Considering that Pse biosynthetic genes 
seem to be spread within regions coding for glycosylation and/or surface components, the available 
information about the proteins and genes responsible for the various modifications observed remains 
limited. 
 
1.4 Integration in bacterial glycans and biological roles 
After synthesis, activated NulOs are expressed on the surface of the bacterial cell where they influence 
the survival capabilities of the bacteria, through the modulation of adhesion and motility as well as 
providing protection against the environment. This is particularly relevant in the case of pathogenic 
bacteria, with surface NulOs serving both as antigens and means to evade host immune systems. 
 
1.4.1 NulOs in cell surface components 
The CMP-NulOs obtained by either de novo biosynthesis or from the environment are incorporated 
within different structures of the outer cell surface depending on the species. The lipopolysaccharide 
(LPS) structures of Gram-negative bacteria house the greatest variety of NulOs, which form diverse 
antigens. The LPS of E. coli O171 and O104 contain di- and tri-acetylated Neu, respectively [41, 146]. 
Several derivatives of Pse are present in Pseudomonas aeruginosa, and Leg was originally identified from 
the LPS of Legionella pneumophilia [54, 76]. 
Several bacteria are known to produce a polysialic acid capsule, which is composed of homo- or 
heteropolymers of Neu5Ac with different linkages [24, 25, 27]. In E. coli K1, polysialic acid capsule 




polysialic acid and NeuE a putative glycosyltransferase involved in the transfer onto the acceptor [147]. 
The Aci derivatives are found in the capsule of A. baumanii [20, 21, 148]. NulOs are also incorporated in 
glycoproteins, via the sequential O-glycosylation system. Flagellin subunits are modified with Leg 
and/or Pse in several species, and the pilin from Pseudomonas aeruginosa contains Pse [43, 47, 75, 149]. 
In Tannerella forsythia, Pse and Leg are found in glycoproteins of the S-layer [66, 88]. 
 
1.4.2 Role in survival and pathogenicity 
Bacterial NulOs are involved in numerous processes relating to both cell integrity and communication 
with its environment, such as a host [73, 150]. The most striking example of the latter is the ability of 
pathogenic bacteria to evade the host immune system by coating their surface with NulOs structurally 
similar to- or directly from- host sialic acids [151, 152]. Depending on the type of sialylconjugate that is 
emulated, different parts of the host immune response are affected [153-155]. In a paradoxal way, the 
fact that Leg- and Pse-related compounds are exclusively synthetized by bacteria gives them antigenic 
properties. They also make bacteria sensitive to bacteriophages that recognize nonulosonic acid 
modifications [156, 157]. 
Aside from molecular mimicking, NulOs influence bacterial motility through flagellin glycosylation, 
which has been shown to be essential for flagella formation in several species [47, 158, 159]. Whether 
NulOs from the LPS are also involved in motility regulation remains to be investigated [160, 161]. In 
addition to motility, host colonization is affected by biofilm formation as well as similar multi-cell 
structures, again involving NulOs [162, 163]. It is important to note that the role of NulOs in 
pathogenicity is not limited to bacterial NulOs. Sialic acids from vertebrates are recognized by a number 
of pathogen proteins, not necessarily from bacteria [164]. The most famous example is the recognition 
and removal of host sialic acids by hemagglutinins and sialidases (neuraminidases) from influenza 





1.4.3 NulOs in A. salmonicida, M. viscosa, and A. wodanis 
A. salmonicida, Aliivibrio wodanis, and Moritella viscosa are fish pathogens causing cold water vibriosis 
and winter ulcer, diseases that particularly affecting farmed fish [166, 167]. In particular, M. viscosa and 
A. wodanis have been shown to co-infect Atlantic salmon and influence each other [168, 169]. Both A. 
salmonicida and M. viscosa can produce mono- (Neu5Ac) and di- (Neu5Ac7(9)Ac) acetylated Neu 
variants, and Leg5Am7Ac has been detected in the LPS of A. salmonicida [19, 37, 71, 101, 170]. Their 
genomes contain each a Neu a cluster for which the NeuB homologs have been characterized, as well as 
a Leg (A. salmonicida, shown in Figure 6) and a Pse (M. viscosa) cluster [36, 37, 133, 168]. While the 
presence of NulOs in A. wodanis has not been investigated yet, its genome contains a cluster that is 
similar to that of V. vulnificus, which produces Leg5Ac7AcAla [73]. 
 
1.5 NulO synthesis using GlcNAc epimerases 
1.5.1 NulOs in research and industry 
NulOs produced by pathogenic bacteria are involved in evading the host immune system by mimicking 
host sugars, but they can also act as antigens due to their unique structures. In addition, host sialic acids 
are the target of neuraminidases of bacterial and viral origin, a key factor in the spreading of pathogens 
such as influenza viruses in host tissues [171]. Because of this, they are prime targets for the synthesis 
of antibiotics based on their structures [172-174]. Applications of NulO analogues are not limited to 
antibiotics, however. Neu analogues can be used to regulate sialic acid synthesis in mammals, and a 
method for labelling of Pse-producing bacteria using an analogue of its precursor has been developed 
[175, 176]. With the importance of NulOs in pathogenicity also comes the necessity to unravel their 
biological roles and understand their metabolism, catabolism, as well as the regulation mechanisms that 
influence them. 
In vertebrates, sialic acid is involved in numerous physiological processes [177]. Its presence in 
breastmilk, with its potential role in brain development, prompts its inclusion in infant formulas [178]. 
Polysialic acid could be used to promote axon repair, and its poor immunogenicity also makes it a good 
candidate for drug delivery systems [179, 180]. As a marker, upregulation of sialylation is a cancer 






Considering their biological relevance, the demand for NulOs compounds is high, higher than their 
availability, and several strategies are pursued for their synthesis. Early methods for the production of 
Neu were focused on purification from natural sources, but they have been abandoned due to the low 
final yields [183, 184]. The current “biological” methods use whole-cell approaches with engineered 
bacteria [185-187]. They have been used for the synthesis of compounds from all three families as well 
as polysialic acid, with promising results. Various chemical synthesis methods have also been used and 
are still developed today [188-191]. They are however often complicated and resource hungry, and a 
variation consists in using N-acetylneuraminic acid aldolase, also known as N-acylneuraminate lyase 
(NAL, EC 4.1.3.3), for the condensation of chemically produced ManNAc with pyruvate [192-194]. 
Another chemo-enzymatic synthesis method using macrophomate synthase has recently been proposed 
[195]. The last strategy uses purified enzymes for the in vitro enzymatic synthesis of Neu compounds. 
The native enzymes from the NAB pathways are used mainly for the goal of their elucidation, while NAL 
enzymes coupled with N-acetyl-glucosamine 2-epimerases (AGEs, EC: 5.1.3.8) are more commonly used 
for synthesis purposes [122, 137, 196-202]. The AGE/NAL pair is used as soluble or immobilized 
enzymes, and some whole-cell methods also use them [202-205]. 
1.5.2 The AGE/NAL coupled reaction 
The reactions catalyzed the N-acylneuraminate lyase and N-acetyl-glucosamine 2-epimerases were first 
described in the 1960s, while the coupled reaction (see Figure 8) was first used for Neu5Ac synthesis 
30 years later [196, 206, 207]. The equilibrium of each of the reactions favors the opposite direction 
from Neu5Ac synthesis, but, compared to other methods of production, enzymatic synthesis still offers 
high yields at a relatively low cost [198, 208]. The use of AGEs and NALs instead of the metabolic 
enzymes is also cost-related. NAL uses pyruvate as co-factor while NeuB uses PEP, which almost 20 
times more expensive. The use of AGEs allows synthesis from GlcNAc instead of ManNAc, three times 
cheaper, even though they require at least catalytic concentrations of ATP as allosteric regulator [197, 
202]. UDP-GlcNAc, the NeuC substrate, is even more expensive than ManNAc. 
 
 
Figure 8. Neu5Ac synthesis using AGE and NAL. The equilibrium constants determined by [207] and [196] are indicated 






Several studies on the parameters of both reactions as well as the synthesis process have been 
performed, and a kinetic model representing the system has been proposed [208]. As mentioned earlier, 
the equilibriums are in the favor of the formation of GlcNAc and ManNAc, respectively; the rate-limiting 
step was shown to be the condensation reaction [202]. In order to push the equilibrium towards the 
synthesis of Neu5Ac, an excess of pyruvate is used. However, pyruvate inhibits AGEs and it has a similar 
pKa to that of Neu5Ac, which makes their separation by ion-exchange chromatography difficult [196, 
209]. Increasing the amount of ManNAc available for the condensation by using an excess of GlcNAc also 
shifts the equilibrium towards Neu5Ac, and both ManNAc and GlcNAc can easily be separated from 
Neu5Ac. NAL is however inhibited by GlcNAc [194]. Optimization is then achieved by managing the 
ratios of substrates and enzymes [196, 202, 208]. 
A critical factor of this process is the enzymes themselves, motivating the characterization of both AGEs 
and NALs in multiple organisms in search of candidates suitable for Neu5Ac synthesis. For example, 
NALs with higher catalytic efficiency would raise the speed of the rate-limiting step of the reaction. One 
such candidate was characterized recently [210]. Enzymes that are less sensitive to inhibition would 
also be an advantage and using AGEs that do not require ATP would considerably reduce the cost of the 
reaction. In this regard, the AGEs from rat and Anabaena variabilis are good candidates, requiring only 
a fourth of the ATP concentration needed by other enzymes [202, 211]. In addition to this are 
considerations on temperature, buffer, and pH requirements. 
The characterization of new AGEs and NALs also allows for a further understanding of their mechanisms 
and requirements, opening the possibility for their engineering. Structural determinations are a 
valuable source of information, and numerous structures are available for both NAL wild-types and 
mutants, including one from A. salmonicida [212]. For comparison, only 2 structures are available for 
AGEs, and several aspects of their properties remain unclear [213, 214]. No AGE structure exists in 
complex with either substrate, inhibitor nor nucleotide, thus providing no definite proof so as to how 





1.6 GlcNAc epimerases: characteristics and bioprospecting 
1.6.1 Reaction mechanism and regulation of AGEs 
AGEs belong to the enzyme class of isomerases acting on carbohydrates and derivatives (EC: 5.1.3.-). 
They catalyze the reversible epimerization of ManNAc to GlcNAc via deprotonation/reprotonation, with 
an acid/base catalytic pair [207, 214-216]. In the current accepted model, the acid moiety abstracts the 
proton carried by the C2 position of the substrate in open form, leading to an enolate intermediate. The 
base donates a new proton to it on the opposite face of C2, thus inverting the configuration at this 
position. The residues involved in those steps have been shown to be a Glu and Arg for the AGE from 
Pedobacter heparinus (PhGn2E), its reaction mechanism presented in Figure 9 [216]. 
 
Figure 9. Model for the reaction mechanism of PhGn2E. The deprotonation/reprotonation mechanism was determined 
by deuterium exchange experiments, and the involved residues (Glu314 and Arg63) were identified by mutagenesis. Figure 
taken from [216]. 
Activity of AGEs is modulated mostly by the presence of nucleotides, in particular ATP [202, 211, 217]. 
It is not consumed during the reaction but can be essential and enhances AGE activity up to 20-fold. The 
manner of its regulation mechanism is not known, and the connection between cellular ATP levels and 
AGE activity has not been investigated yet. 
AGEs are inhibited by pyruvate and Neu5Ac, as well as renin, although it can also be activated by the 
latter [218]. For a time, they were identified as renin-binding proteins (RnBP), until their cloning 
revealed their true nature [219, 220]. This raised the question of whether AGEs were involved in the 
renin-angiotensin system (RAS), which regulates blood pressure, due to their ability to specifically 
inhibit renin and their coexistence in renal tissues [221, 222]. However, it was shown that mice lacking 
RnBP are normotensive and that neither renin expression nor activity was affected [223]. Investigations 
on their role in mammals suggest that they may participate in sialic acid catabolism [224]. As for 





1.6.2 Biochemical properties of characterized AGEs 
The first AGE to be characterized, pAGE, was isolated from hog kidney [207]. It was used to determine 
the equilibrium constant of the reaction (Keq=3.9 in favor of GlcNAc formation), the affinity of pAGE for 
its substrates (Km=3.4 mM for GlcNAc and 3.3 mM for ManNAc), and its ATP requirement (Km=1.1 mM 
for the epimerization of GlcNAc to ManNAc). Further studies on the role of ATP revealed it to act as a 
non-essential allosteric activator, and it was shown that other nucleotides could replace it, albeit with 
different affinities and effects on enzyme activity [211, 217]. The protein was later found to elute as a 
dimer, with a monomer mass around 45 kDa and three cysteine residues involved in dimer interface 
[219, 225, 226]. It is inhibited by renin, pyruvate, and Neu5Ac [196, 219, 227]. Other mammalian AGEs 
have also been characterized, with the human enzyme (hAGE) showing an absolute requirement for ATP 
[211, 220]. The rat enzyme (rAGE) was shown to have an especially high affinity for ATP and was 
likewise activated by ADP. 
The first bacterial AGE to be characterized was from Synechocystis sp., with properties similar to that of 
the porcine and human enzymes [199]. A turning point was reached when the enzyme from the 
cyanobacterium Anabaena sp. was characterized, revealing a 4-fold higher activity coupled with a 100-
fold lower dependency on ATP [202, 214]. It was also activated by AMPPNP, the non-hydrolysable 
analog of ATP, confirming previous observations that ATP is indeed not used in the reaction. The 
potential of AnaAGE for use in Neu synthesis prompted further studies on several cyanobacterial AGEs, 
and the enzyme from Anabaena variabilis (AvaAGE) was shown to be less sensitive to pyruvate while 
having similar activity and ATP affinity as AnaAGE [227]. Bacterial AGEs from other families have also 
been studied [216, 218]. 
In order to identify the residues critical to AGE function and regulation, numerous mutagenesis studies 
have been performed [214, 215, 228-232]. From these studies, several residues critical to AGE activity, 
inhibition, and ATP-binding could be identified. Such residues are the C380 of hAGE or the active site 
residues of AnaAGE. Two putative sites for ATP-binding were proposed, but lack of AGE structures 
complexed with ligands prevents the definitive identification of the residues involved [202, 218, 229-
231]. This holds true for the catalytic residues as well, which are suspected to be a Glu/Arg pair although 





1.6.3 Structure of AGEs and the AGE superfamily 
As mentioned earlier, only two AGE crystal structures are available as of the end of 2018 [213, 214]. 
They are from pAGE and AnaAGE, with the latter using the former as template for molecular 
replacement. Figure 10 presents an overview of the pAGE and Ana AGE structures, with the AGE 
monomers consisting of 12 helices folding as a (α/α)6-barrel. The faces of the AGE barrel can be designed 
as “front” and “back”, according to the length of the loops that join each pair of helices. The front face is 
then the one where the loops are long, whereas the back face has short loops. Both crystals belong to 
the same space group (P212121), and the unit cell is composed of two monomers interacting via their 
back faces. 
 
Figure 10. Crystal structures of pAGE and AnaAGE. A: AGE unit cell (polymer only) for pAGE and AnaAGE. The 
AnaAGE protein chains, colored in a pink palette along the residue count, is superimposed onto that of pAGE, which is 
represented in a brown palette. The superimposition was obtained by structural alignment of the Cα. The missing loop of 
AnaAGE is indicated by black arrows, and the corresponding residues are labelled. Only the N- and C-terminal residues 
of pAGE are visible, they are indicated. B,C: Back face of the AnaAGE (B) and pAGE (C) monomers. Α-helices are 
numbered along the amino-acid sequence, and the residues surrounding the missing loop of AnaAGE are labelled. The 




The (α/α)6-barrel fold of AGEs is common amongst sugar metabolizing enzymes, even though their 
sequences are diverse [213, 214]. In particular, AGEs form, together with cellobiose 2-epimerases (CE; 
EC 5.1.3.11) and yihS-encoded sulfoquinovose isomerases (EC 5.3.1.31), the AGE superfamily (Pfam 
accession No. PF07221) [233, 234]. The structural comparison of pAGE and YihS from Salmonella 
enterica, which is in complex with mannose, showed that active site residues were conserved between 
the two enzymes [235]. 
 
1.6.4 Cyanobacterial sources for AGEs and NGS technology 
As mentioned above, it seems that AGEs from cyanobacterial sources are the best suited to the synthesis 
of Neu5Ac. Cyanobacteria are a very diverse group found in all kinds of environments. They are able to 
perform oxygenic photosynthesis, the only prokaryotes to do so, playing a significant role in the 
oxygenation of the Earth’s surface and atmosphere [236]. They are able to fix carbon and nitrogen, as 
well as produce secondary metabolites that can be used for a wide range of applications such as bio-
fuels, biocides or pharmaceuticals [237-241]. 
For these reasons, cyanobacteria are a target for bioprospecting endeavors around the world [242-245]. 
The success of these studies largely depends on the technologies that have been developed in the last 
two decades, in particular next-generation sequencing (NGS). Indeed, up until 2005 the main way to 
obtain genetic data was by the Sanger method [246]. This method exploits the inability of DNA 
polymerase to extend a nascent DNA chain from a dideoxy base (ddNTP), because it has no 3’-hydroxyl 
group [247]. Using a fraction of ddNTP, the reaction leads to a range of DNA fragments of various sizes, 
each ending by the chosen base [248]. The reaction is performed in parallel for each nucleotide, and the 
fragments are separated according to size by electrophoresis on acrylamide gel. The original was 
improved by several advancements over the years, such has the use of capillaries instead of gels, 
fluorescent terminators and polymerase chain reaction [249, 250]. 
Several NGS methods are available, which can be classified in two groups according to whether they use 
single-molecule or PCR-amplified DNA templates. They are described and illustrated in a comprehensive 
way in the review by Metzker et al. [251]. For single-molecule DNA sequencing, the most commonly 
used technique is sequencing-by-synthesis, where fluorescent nucleotides are excited as they are 
incorporated by DNA polymerase [252]. The sequencing methods requiring amplified templates include 
cyclic reversible termination (CRT), sequencing by ligation (SBL), single-nucleotide addition 
(pyrosequencing), and real-time sequencing [251].  
CRT uses reversible terminators, that is modified nucleotides triggering the termination of synthesis, 
but for which the 3’-blocking group can be removed, thus allowing further elongation by DNA 




templates and primers are immobilized on solid support. Primers are then extended by one base, 
because all present nucleotides are terminators. After washing away the free nucleotides, the newly 
incorporated base is identified by the color of its fluorophore. Both the fluorescent tag and the 3’-
blocking group are then removed, and a new cycle of extension can be performed (after washing away 
the cleavage products). 
Pyrosequencing also uses DNA polymerase, but instead of using a mix of terminator nucleotides, it uses 
a single type of dNTP in limiting amounts for the extension reaction [253, 254]. Incorporation is not 
detected by fluorescent nucleotides, but by following the release of inorganic pyrophosphate using 
quantitative bioluminescence. The extension reaction is paused after incorporation, and the excess 
nucleotide is either washed or degraded. A new cycle can then be performed with a new dNTP. 
In the case of real-time sequencing, the incorporation of fluorescent nucleotides (for which the tag does 
not interfere with the polymerization reaction) is measured in real time, while they are retained in the 
active site of an immobilized DNA polymerase.  The method heavily reposes on the detection volume, 
which has to be localized around the DNA polymerase so as to avoid the presence of other fluorescent 
dNTPs. 
For SBL, fluorescent oligonucleotide probes containing either one or two interrogation bases and a few 
universal and degenerate bases are used in a cyclic ligation reaction. Probes are incubated with the 
template/primer pair for hybridization. DNA ligase is then added to the reaction mix in order to join the 
hybridized probe to the primer. After washing, the identity of the probe is revealed by fluorescence 
imaging. As for the nucleotides used in CRT, the probes are regenerated by removing their fluorescent 
tag and, in this case, regenerating the groups necessary for further ligation reactions. Several variations 
of this method exist, with different combinations of primers and probes. 
Independently of the method used, the improvement was such that it is now common to sequence entire 
genomes as well as metagenomes as a part of other studies rather than stand-alone projects. The data 





2 Aims of the study 
This study is a part of a bigger project that aims to explore NulO biosynthesis in the A. salmonicida and 
M. viscosa fish pathogens. The characterization of the enzymes composing their NAB pathways is a major 
aim for the group, and the NeuB homologs from the Neu pathway have been characterized [36, 37]. The 
cloning, expression and characterization of acetyltransferases was the primary aim of this study, 
however the difficulties in cloning and expressing those proteins lead to the termination of this part of 
the project for the time being. Instead, it was chosen to focus on bioprospecting sources for 
cyanobacterial AGEs. Indeed, the ability to efficiently synthetize Neu from GlcNAc presents several 
advantages and opens multiples possibilities for the project. In this direction, the NAL from A. 
salmonicida has been characterized, and only the AGE remains for us to perform the coupled reaction 
necessary for Neu5Ac synthesis [212]. The two Nostoc sp. strains KVJ10 and KVJ20 were chosen as 
sources for AGEs, the former with its genome already sequenced and annotated. Again, the final aim was 
the characterization of the protein products. 
The other aim of the study was to map the kind of NulOs produced by these bacteria, taking advantage 
of a database of local strains from the same species. Considering the diversity of nab clusters within 
species of the Vibrionaceae family, it is reasonable to expect multiple unique clusters even within a set 
of closely related organisms [23, 255]. Those clusters might direct the biosynthesis of previously 
undescribed NulOs. In addition to this, the analysis of the protein coding sequences might provide us 





3 Summary of Papers 
3.1 Paper I 
Analysis of nonulosonic acid biosynthetic gene clusters in Aliivibrio salmonicida and Moritella 
viscosa. 
Halsør MJH, Altermark B, Ræder ILU. 
Exploration of the diversity of NulOs in bacteria is at its beginnings, and new bacterial NulOs keep being 
identified. The sequencing of numerous bacterial genomes presents a source of data concerning their 
nab gene clusters, and their analysis indicates which type of NulO might be produced. Considering the 
highly variable nature of nab clusters, it may also reveal new genes leading to previously unidentified 
compounds. This paper presents the study of nab gene clusters in a set of A. salmonicida and M. viscosa 
strains, with the identification of three unique clusters for which NulO structure was predicted. The 
NulO content of A. salmonicida LFI1238, M. viscosa 06/09/139, A. wodanis 06/09/139, A. salmonicida 
R8-63 and Vibrio B9-25K2, the two latter with a new nab cluster, was released and labelled with 1, 2-
diamino-4, 5-methyleneoxybenzene (DMB). The quinoxalines were analyzed by LC-MS, revealing an 
unidentified peak at m/z = 530 for that of A. salmonicida R8-63 and verifying the presence of PseAc2 for 
Vibrio B9-25K2. MS/MS analysis of the PseAc2 compounds from M. viscosa and Vibrio showed that they 
do not share the same configuration. Considering the unknown coding sequences in the nab cluster of 
Vibrio, it may produce the first epimer from the Pse pathway to be reported. In addition to this, the 
sequences for NeuB homologs were investigated for the presence of specificity regions, which 
discriminate between Neu, Leg, and Pse substrates. A critical residue for the specificity of the Pse 
pathway was thus identified. 
 
3.2 Paper II 
Draft genome of the Self-Cleaning Cyanobacterium Nostoc sp. KVJ20. 
Halsør MJH, Liaimer A, Ræder ILU, Pandur S, Smalås AO and Altermark B. 
The cyanobacterium Nostoc sp. KVJ20 was isolated from the symbiotic organs of the liverwort Blasia 
pusilla L., which is found as a weed in a plant-school on the island of Kvaløya, Northern Norway. Its “self-
cleaning” properties as well as the potential applications for its cellular components motivated the full-
length sequencing of its genome. It totals 9,183,495 bp distributed amongst 425 contigs forming 332 
scaffolds, with 41.69% GC. 7,676 genes were identified, with 7,210 protein coding sequences and 104 
RNA genes. Several biosynthesis clusters for secondary metabolites that may confer its antibiotic 




3.3 Paper III 
The crystal structure of the N-acetyl-D-glucosamine 2-epimerase from Nostoc sp. KVJ10 reveals 
the true dimer. 
Halsør MJH, Rothweiler U, Altermark B, and Ræder ILU. 
AGEs catalyze the interconversion of GlcNAc and ManNAc. They are used industrially to synthetize sialic 
acid, and enzymes from cyanobacterial sources possess the best kinetic parameters of all characterized 
AGEs. This paper presents the crystal structure of the AGE from the local cyanobacteria Nostoc sp. KVJ10 
(called nAGE10), which differs from previously published AGE structures in that the dimer organization 
is different while the monomer folds in an identical fashion as a (α/α)6-barrel. The new dimer involves 
the faces of the monomer where the helices are linked by long loops (“front” faces), while the previous 
organization was “back-to-back”. The “front-to-front” dimer has better parameters in terms of 
interaction surfaces and allows a better explanation of observations made earlier from biochemical 
experiments. In addition to this, the nAGE10 dimer, which was crystallized in a different space group 
than that of previous structures, can be generated by symmetry within those structures, while the “back-
to-back” dimer can’t. Taken together, these results strongly suggest that the new dimer represents the 





4 Results and Discussion 
4.1 Diversity of nab clusters in Vibrionaceae 
With the goal of exploring NulO biosynthesis in A. salmonicida and M. viscosa, we investigated in paper 
I the genomes from a set of strains from these bacteria. We also included strains of other species such 
as A. wodanis, which is known to co-infect together with M. viscosa¸ Vibrio, and Photobacterium¸ the latter 
as a negative control since it is known to not produce NulOs (see Table 1, paper I). In order to do this, 
we first identified potential nab clusters by searching for NeuB homolog protein sequences, the only 
enzyme of NulO synthesis that is common to all pathways. The queries used were the NeuB sequences 
from the published A. salmonicida LFI1238 (2 sequences, Neu and Leg pathways), A. wodanis (1 
sequence, Leg pathway) and M. viscosa (2 sequences, Neu and Pse pathways) 06/09/139 strains, 
covering at least one sequence per pathway [133, 168]. 
The results revealed that all the strains apart from the Photobacterium and Vibrio anguillarum ones 
possessed at least a NeuB homolog sequence, as was expected. Amongst the 8 M. viscosa strains, 6 of 
them possessed sequences identical to both homologs from the M. viscosa query, the two remaining 
(strains F57 and NVI5482) having one sequence identical to each of the query homologs, respectively 
(Neu pathway homolog for F57 and Pse pathway homolog for NVI5482). Within the four A. salmonicida 
strains, two possessed sequences identical to both homologs from the A. salmonicida LFI1238 query 
(strains R8-68 and R8-70). The other two strains contained unique NeuB sequences, closest to the NeuB 
homologs from the Leg pathway from either the A. salmonicida (strain MR17-77, 97% sequence identity) 
or A. wodanis (strain R8-63, 97% sequence identity) queries. The last sequence in the set, from Vibrio 
B9-25K2, was closest to the NeuB homolog from M. viscosa from the Pse pathway, although the sequence 
identity was only 57%, against identities above 90% for the rest of the sequences investigated. 
Considering this, a wider database search was performed using this sequence, leading to closer 
sequences (around 80% sequence identity) from other Vibrio species, but still corresponding to the Pse 
pathway according to their annotation. 
Once the NeuB homologs were identified, they were used to investigate the presence and content of nab 
clusters at their locations within the target genomes. All of them indeed presented nab clusters (see 
Figure 3, paper I), supporting the efficiency of using NeuB homolog similarity searches for their 
detection. We were able to assign a putative function to most of the coding sequences by searching 
public databases for similar sequences that were annotated as well as conserved domains. We were thus 
able to identify a putative cytidylyltransferase non-homologous to NeuA for Vibrio B9-25K2. The 
comparison of gene content and organization of each cluster revealed that in the case of identical NeuB 
sequences, the corresponding nab clusters were also identical although this was only true for our set of 




the clusters were different. This is especially obvious in the case of A. salmonicida R8-63 (similar to A. 
wodanis) and MR17-77 (similar to A. salmonicida LFI1238), which NeuB sequences share 97% identity 
with that of their closest homologs but still have different clusters.  
The cluster analysis confirmed the information gained from the comparison of NeuB sequences and gave 
further insight so as to what the final NulO produced by each strain may be, at least in part. All the M. 
viscosa strains except of NVI5482 are expected to produce NeuAc and NeuAc2, the latter due to the 
presence of an N-acetyltransferase within the cluster. For Pse, only the F57 should not be able to 
produce PseAc2. The A. salmonicida strains R8-68 and R8-70 should produce NeuAc, NeuAc2, and 
LegAmAc. It is expected that A. salmonicida MR17-77 and R8-63 produce compounds similar to LegAc2 
and Leg5Ac7AcAla, respectively. In the case of Vibrio B9-25K2, it might produce PseAc2 unless the 
unknown protein domains/sequences within its NAB cluster are responsible for major modifications.  
The hypotheses concerning NulO structure were investigated further by analyzing the NulO content of 
these bacteria (labelled with DMB) using mass spectrometry. A. salmonicida LFI1238, M. viscosa and A. 
wodanis were also included both as positive controls and in order to verify the presence of Pse and 
Leg5Ac7AcAla in the last two. Compounds with masses corresponding to the expected NulOs from A. 
salmonicida, M. viscosa and A. wodanis were found, thus confirming their presence. Tandem mass 
spectrometry was performed for the compounds corresponding to LegAmAc and PseAc2, as it had not 
been done previously. Vibrio B9-25K2 seems to produce a compound that, while corresponding to the 
mass of PseAc2, is different from that produced by M. viscosa, the respective compounds having different 
retention times and fragmentation spectra. A. salmonicida R8-63 produces a NulO of higher mass than 
Leg5Ac7AcAla which has not been previously reported. A. salmonicida MR17-77 could not be grown at 
the time of the experiment and was therefore not analyzed. 
 
4.2 Determinants for NeuB substrate specificity 
The three pathways for the biosynthesis of NulOs are distinguished by different nab gene clusters coding 
for enzymes specific to each of them. The ones that carry the same activity are however often homologs, 
the most conserved being the N-acetylneuraminic acid synthase NeuB, which catalyzes the condensation 
reaction between the hexosamine precursor of each pathway and phosphoenolpyruvate (PEP) to give 
Neu, Leg, or Pse, respectively. In order to investigate the residues involved in substrate specificity, we 
compared in paper I the structure of the NeuB active site from N. meningitidis (nmNeuB) to the 
sequences of the homologs from C. jejuni NCTC11168 (cjNeuB1-3), the only species known to produce 
all three types of NulOs [103, 256]. Its NeuB homologs, while from different pathways, are from the same 





Two regions within the active site could be described, a strictly conserved “catalytic region” comprising 
of the PEP binding site as well as the residues binding the substituents at the C1 position of the sugar 
substrate and a “specificity region” binding the rest of the hexose, which varied between isozymes (see 
Figure 2, paper I). In nmNeuB, this region is composed of residues Q55, N74, Y186, H236, D247 and 
R314 which directly interact with the reduced ManNAc (rManNAc) ligand. R314 interacts with the NAc 
group at C2, Q55 and D247 with the -OH at C3, the latter also interacting with the -OH at C5. N74 is in 
contact with the -OH groups at C5 and C6. Three water molecules are also involved; they are coordinated 
by N74 and R314. Comparison with the C. jejuni NeuB model from the same pathway (cjNeuB1) showed 
that all those positions were conserved between the two enzymes (Figure 2A, paper I). Within 4Å of the 
ligand (near PEP and the Mn2+), only C182 is replaced, by a threonine residue. 
In the model corresponding to the Leg pathway homolog (cjNeuB2, see Figure 2B, paper I) the region in 
proximity of C6 has a different geometry, with the positions corresponding to N74, I79 and M83 
occupied by other residues (Tyr, Gln and Val, respectively). The loop carrying N74 has a completely 
different sequence and geometry in cjNeuB2, none of its residues appearing to be involved with 
substrate binding. This reflects the difference between the substrates of the two enzymes, the Leg 
precursor 2,4-diNAc-2,4,6-trideoxy-mannose lacking the -OH group present at C6 of ManNAc. The only 
other difference between the Neu and Leg precursors is the C4 position, occupied by -OH in ManNAc 
and a NAc group in the latter (but sharing the same configuration). The sites are almost strictly 
conserved at this location, except for M83 (replaced by Val). In nmNeuB, the OH of rManNAc only 
interacts with a water molecule, which position could be taken by the NAc group of the Leg precursor 
(the M83V mutation providing extra space). The Q55 and D247 positions are conserved, as expected 
considering that the C3 position is identical for all NeuB substrates. 
The NeuB homolog from the Pse pathway (cjNeuB3) accepts 2,4-diNAc-2,4,6-trideoxy-altrose as a 
substrate, which differs from ManNAc in several more aspects than the Leg precursor. While both lack 
an OH group at C6, the configuration of their chiral centers at C4 and C5 are different, and it is reasonable 
to assume that the active sites of their respective NeuB homologs would be different at this location (as 
well as being different from cjNeuB1). Indeed, the M83 position of nmNeuB, conserved in cjNeuB1 and 
Val in cjNeuB2, is occupied by a phenylalanine in cjNeuB3. Similarly, The I79 position is occupied by a 
leucine residue (Ile in cjNeuB1 and Gln in cjNeuB2). The third position of interest, occupied by N74 in 
nmNeuB, was carried by a loop which was different in cjNeuB2 (but conserved in geometry, if not 
sequence, between nmNeuB and cjNeuB1). This is also the case for cjNeuB3, for which the loop is 
different in both sequence and geometry. The second difference between the Leg and Pse precursors is 
their configuration at C2, with the NAc group in an orientation similar to that of rManNAc for the Leg 
precursor but different for the latter. This difference is reflected within the NeuB active sites, with the 




Those positions are strictly conserved between nmNeuB and cjNeuB1, while they are occupied by a Gly, 
Thr, Asp and Val in cjNeuB2. Again, the residues involved with specificity at C3 are conserved. 
Our goal was to explore NulO biosynthesis in A. salmonicida, A. wodanis and M. viscosa, and thus we 
constructed a NeuB alignment with sequences from those organisms (as well as the Vibrio B9-25K2 
strain, because it had a unique NeuB sequence), presented in Figure 1 from paper I. Its analysis, also 
considering the pathway specific alignments previously published, confirmed that the positions 
highlighted by the active site comparison were indeed of interest. Most notably, the G133 position of 
nmNeuB, conserved in cjNeuB1 and cjNeuB2 but replaced by Phe in cjNeuB3, was also conserved 
according to pathway for our set of Vibrionaceae NeuB sequences. Sequences identified as Pse-pathway 
homologs have Phe while the other ones have Gly, suggesting that this position may be critical for the 
specificity at the C2 position of NulO substrates. Specificity at C4-C6 involves the same set of residues 
and is dependent on both the nature of the substituents in C4 and C6 and the configuration C4 and C5 
chiral centers. Leg and Pse substrates carry an NAc group in C4 while Neu substrates carry an OH group, 
but may have an OAc if NeuD containing organisms use 4-O-acetylated-ManNAc as a substrate [36]. This 
hypothesis is strengthened by the local geometry of the nmNeuB active site, with the water molecule as 
interaction partner for the OH at C4. As for Leg compounds, it is reasonable to imagine this water 
replaced by a substituent at C4. Considering the configuration at C4 and C5, we know that the Neu and 
Leg substrates have the same absolute configuration, but not the Pse precursor. It would thus make 
sense that the NeuB residues interacting with those positions are more conserved across the Neu and 
Leg pathways than they are with the Pse pathway. Taken together, these observations make it difficult 
to assign specific positions to each pathway with our limited set of sequences. They however explain the 
sequence variations within the concerned region and highlight its importance. 
 
4.3 Sequencing of Nostoc sp. KVJ20 
The study of NulOs requires that they are made readily available, which is not currently the case. Our 
group is pursuing the possibility of Neu synthesis via the AGE/NAL coupled reaction, using the NAL from 
A. salmonicida [212]. Considering the promising qualities of cyanobacterial AGEs, we screened genetic 
data from environmental samples for their presence. The data was produced by the Microorganisms 
and Plants research group at the Department of Arctic and Marine Biology at UiT. The group has been 
studying the role of secondary metabolites in Nostoc spp., with an emphasis on regulation of cell 
differentiation and cell-cell communication [257-259]. As a part of their work, they have collected 
isolates from the liverwort Blasia pusilla L. which occurs naturally in the region surrounding Tromsø 
and has a symbiotic relationship with nitrogen-fixing cyanobacteria. They have classified these isolates 




PCR screening for AGE coding sequences was performed and two target strains, Nostoc sp. KVJ10 and 
KVJ20 were thus obtained. Both were used for sequencing, but only the data pertaining to KVJ20 was of 
sufficient quality. The draft genome sequence of Nostoc sp. KVJ20 is reported in paper II. 
The genome totals 9,183,495 bp distributed amongst 425 contigs forming 332 scaffolds, with 41.69% 
GC. 7,676 genes were identified, with 7,210 protein coding sequences and 104 RNA genes. The genome 
was found to be closest to that of Nostoc punctiforme PCC73102 [260]. The Nostoc genus is a focus of the 
Microorganisms and Plants research group at UiT- The Arctic University of Norway, and this particular 
strain presents an interest for them because of its “self-cleaning” ability. As such, paper II focuses on the 
genes involved in the synthesis of secondary metabolites likely to confer antibiotic properties to the 
strain rather than the one AGE coding sequence the genome contains. Nevertheless, the sequence was 
cloned and the AGE, referred to as nAGE20, was expressed and purified (data not shown). It was capable 
of Neu synthesis in vitro but crystallization attempts were unsuccessful, and those results were not 
included in any paper. 
 
4.4 Characterization of nAGE10 from Nostoc sp. KVJ10 
Paper III reports the crystal structure of AGE from Nostoc sp. KVJ10 (nAGE10), another target 
cyanobacterial strain from bioprospecting. The crystals were obtained using the hanging-drop vapor 
diffusion method and diffracted to a resolution of 1.7Å. The structure was solved by molecular 
replacement (R=0.176) using the AGE structure from Anabaena variabilis (AnaAGE, PDB ID: 2GZ6) as 
template, the two proteins sharing 90% sequence identity [214]. As expected, the tertiary structure of 
nAGE10 is very similar to that of AnaAGE, with a (α/α)6-barrel fold where the helices are joined by long 
loops on one face (front) and short ones on the other (back). The r.m.s.d. between the two structures is 
0.8, but the crystals belong to different space groups (P42212 for nAGE10 and P212121 for AnaAGE). The 
unit cell of nAGE10 contains a monomer versus a dimer for AnaAGE, which could not be generated by 
symmetry for the nAGE10 crystal. Another favorable dimeric organization was found instead, involving 
the mate issued from the y-1, x+1, -z operation. The difference between the two dimers is that they 
involve different faces of the monomer: the nAGE10 dimer is “front-to-front” while the one presented in 
the AnaAGE structure is “back-to-back”. The front-to-front dimer could be generated for AnaAGE 
(symmetry operator x-1, y, z) and could have been chosen as unit cell instead. The fact the front-to-front 
organization can be found regardless of the space group of the crystal whereas the back-to-back one is 
only found for one of them indicates that the former might be biological unit. This hypothesis was 
strengthened by the comparison of the interfaces for between assemblies for AnaAGE as well as the 
structure of the porcine enzyme (pAGE) it is based on [213]. Interface area, solvation energy and 




back one for both enzymes. Analysis of the conservation of interface residues in sequence and 
distribution for all three AGEs revealed that the front interface is conserved across the species while the 
back interface is not, further supporting our hypothesis. 
Aside from the considerations about the dimer organization of AGEs, the nAGE10 structure provided 
new insights into the structure of the AGE binding site. We compared it with that of the other AGE 
structures (AnaAGE and pAGE) as well as the structures of the other members of the AGE superfamily, 
which share a common fold despite low sequence identity [213, 214, 235, 261]. The active site of 
nAGE10 contains a chloride ion which is also present in that of the cellobiose epimerase from 
Rhodothermus marinus (RmCE; PDB entries 3WKG-I). The “chloride location” is occupied by waters in 
the other structures, but they either have a B-factor that is low compared to that of neighboring waters 
(AnaAGE and pAGE), or the coordinating glycine (G370 of nAGE10) that is conserved in AGEs and RmCE 
is replaced by another residue (cysteine or aspartate). Taken together, these observations suggest that 
AGEs may have a conserved chloride in their active site. 
In addition to the chloride, there is an ethylene glycol molecule in the active site of nAGE10 which, when 
compared to the sites of ligand-bound RmCE, is roughly occupying the positions taken by the end of the 
mannose chain. Because of this, we can assume that the RmCE substrates mimic the position of AGE 
substrates in acceptable fashion, thus making it possible to discuss the position of active sites residues 
relative to them. For example, measuring the distance between the putative AGE catalytic residues and 
the “substrate” revealed that while the arginine position (R68 in nAGE10) is close to the epimerization 
target, the glutamic acid position (E309) is almost 8Å away from it [216]. A closer candidate for the 
glutamic acid partner would be E243, which is only about 5Å from the C2 position of the hexose. Aside 
from catalytic residues, it seems that the AGE binding pocket for the acetyl group carried by 
GlcNAc/ManNAc is formed by F116, I177 and A173 of nAGE10. Those conserved AGE positions are 
occupied by bulkier residues in the enzyme from Pedobacter heparinus, which is not capable of 
epimerizing GlcNAc [216]. At last, W368 might be involved in substrate specificity at the C4 position of 
the sugar substrate. This is especially interesting when considering that this position corresponds to the 
C7 of NulOs, which commonly carries substituents. 
While nAGE10 could not be crystallized in the presence of ATP and the putative ATP-binding loop 
(between the H5 and H6 helices) could not be resolved, the new dimer organization implies that ATP 
binds at the dimer interface. This drastically changes the way we look at AGE regulation by nucleotides, 
which may involve the oligomeric state of the enzyme. In addition to the H5/H6 loop, the glycine-rich 
fragment located at the C-terminus of AGEs, in the H11/H12 loop has also been proposed as putative 
ATP-binding site [231]. This loop is also located at the dimer interface, in a position opposite to that of 
the H5/H6 loop in pAGE, with both loops pointing towards each other. Considering that their orientation 




Apart from the information provided by the structural characterization, it is worth noting that nAGE10, 
which was expressed as a His-tagged protein without chaperones, did not form inclusion bodies. It could 
be purified with high yields in one step by affinity chromatography. It is also active, and Neu5Ac 
synthesis was performed by the AGE/NAL coupled reaction using the NAL from A. salmonicida. The 
reaction could be performed both in the absence and presence of ATP, although only a fraction of 





5 Future perspectives 
Considering that each paper treats a different subject, they cannot be easily discussed in relation to one 
another. They are, however, all within the spectrum of NulO studies, dealing with its genetic, metabolic 
and technical aspects. Papers II and III deal with the necessary preparation steps for NulO studies, from 
the bioprospecting and characterization angles. Paper I adds to the current knowledge about NulO 
diversity as well as investigates the structural details governing NeuB specificity. Together, these papers 
illustrate the range of topics that need to be taken into consideration when exploring somewhat 
uncharted scientific territory.  
The analysis of nab clusters within the chosen set of sequences revealed the unique clusters from Vibrio 
B9-25K2 as well as A. salmonicida R8-63 and MR17-77. The compounds from Vibrio B9-25K2 and A. 
salmonicida R8-63 most likely correspond to previously undescribed derivates of Pse and Leg, 
respectively. They await structural determination, which should provide valuable information on the 
function of the uncharacterized genes from their respective clusters. Whether A. salmonicida MR17-77 
produces LegAc2 remains to be revealed.  
The annotation of the clusters also provided interesting targets for further studies, such as the putative 
cytidylyltransferase from Vibrio B9-25K2 that is non-homologous to NeuA and has a second domain of 
unknown function. Another is the N-acyltransferase from A. salmonicida R8-63. It is similar to the 
putative alanyl transferase from V. vulnificus but may well transfer another residue, considering the 
difference in m/z ratios of the final NulOs [73]. These two and the other uncharacterized proteins from 
these clusters would make good targets for characterization studies and ones involving deletion 
mutants. 
Concerning the NeuB homologs, a whole set of mutagenesis targets were given. These will allow the 
investigation of the requirements for NeuB substrate specificity, which has not been explored before. In 
particular, the positions corresponding to the N74, I79, M83 and G133 residues of nmNeuB seem of 
importance. Other possible experiments include sequence comparison studies using large datasets in 
order to spot further pathway-specific trends and gather evolutionary data. 
Lastly, the information gained by the crystallization of nAGE10 gives new leads of investigation into the 
structural relationship between AGEs and nucleotides, and their role in substrate binding. New data 
concerning the structure of the AGE active site, with the identification of putative buried chloride and 
NAc binding pocket, also provides new targets for mutagenesis. Those are the positions corresponding 
to the F116, I177, A173, W368 and G370 residues of nAGE10. 
The works presented provide further insight into the field of NulO study, opening promising possibilities 
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Abstract 
Nonulosonic acid (NulO) biosynthesis in bacteria is directed by nab gene clusters that can lead to 
neuraminic, legionaminic or pseudaminic acids. Analysis of the gene content from a set of Aliivibrio 
salmonicida and Moritella viscosa strains reveals the existence of several unique nab clusters, which can 
be used to guide tandem mass spectrometry studies. NulOs from several strains were thus identified. 
 
Introduction 
Bacterial nonulosonic acids (NulOs) are 9-carbon α-keto acids found on the cell surface, as parts of the 
capsule, flagella, lipopolysaccharide and pili [1-6]. Neuraminic acids (Neu), a family of 
dideoxynonulosonic acids better known as sialic acids, are most widely spread in vertebrates in which 
they were first discovered [7, 8]. The most common bacterial NulOs are tetradeoxynonulosonic acids, 
although neuraminic acids are also found, and one instance of a trideoxy-compound has been reported 
recently [1, 9]. The various tetradeoxy-NulOs are somewhat classified according to their absolute 
configuration. Legionaminic acid (Leg) is a 5,7-diamino-3,5,7,9-tetradeoxy-D-glycero-D-galacto-non-2-
ulosonic acid, while pseudaminic acid (Pse) is the L-glycero-L-manno isomer [2, 3, 10, 11]. The L-glycero-
D-galacto and L-glycero-D-talo isomers are designated as 8- and 4-epilegionaminic acids, respectively 
[12, 13]. The L-glycero-L-altro isomer is known as Acinetaminic acid (Aci), and the D-glycero-L-altro 
isomer as its 8-epimer [14, 15]. Most recently, the (D/L)-glycero-L-gluco isomer was identified as 
fusaminic acid (Fus), like its trideoxy-counterpart [9, 16]. 
NulOs from pathogenic bacteria play a central role in host-pathogen interactions. Their structure mimics 
that of host neuraminic acids, thus enabling them to bind to the Siglecs (Sialic acid-binding 
immunoglobulin-type lectins) of host immune cells, which mediate the inhibition of immune cell 
activation [17, 18]. As a critical component of flagella and pili they indirectly affect host colonization, 
but also bacterial motility in general [19-21]. In addition to synthetizing NulOs themselves, bacteria can 




NulO biosynthesis is directed by nab gene clusters [24-26]. Neu, Leg and Pse are synthetized by different 
pathways (Nonulosonic Acid Biosynthesis, or NAB), although each contains homologous genes that are 
responsible for the main biosynthesis steps [27]. Aci is synthetized by a set of additional genes affixed 
to the Leg cluster, and the gene cluster responsible for the synthesis of Fus has not been investigated yet 
[14]. The composition and organization of nab clusters varies not only between pathways and species, 
but also within species [27, 28]. Only one gene, coding for the N-acetylneuraminate synthase NeuB, is 
conserved across both pathways and species. The NeuB homologs catalyze the key reaction of NulO 
biosynthesis, the condensation of a hexosamine precursor with pyruvate leading to either Neu, Leg, or 
Pse. 
Aliivibrio salmonicida (formerly Vibrio salmonicida) is a psychrophilic fish pathogen causing cold water 
vibriosis, a disease that used to seriously impact the output of salmon aquaculture before the use of 
vaccines [29-31]. It is known to produce Neu5Ac and Neu5Ac7(9)Ac, and the presence of 8eLeg5Am7Ac 
has been detected in its lipopolysaccharide [32-34]. 
Moritella viscosa is the main agent in causing the winter ulcer disease in salmon and cod, with Aliivibrio 
wodanis as a co-pathogen [35-37]. As for A. salmonicida, Neu5Ac and Neu5Ac7(9)Ac were shown to be 
produced by M. viscosa [38]. The NulO content of A. wodanis has not been investigated so far, but its nab 
gene cluster appears similar to that of Vibrio vulnificus CMCP6, which produces the Leg variant 
Leg5Ac7AcAla [39]. The diversity of nab clusters within Vibrionaceae has already been shown, with an 
emphasis on Vibrio vulnificus [28]. 
This study investigates the presence and composition of nab gene clusters in a set of strains from A. 
salmonicida and M. viscosa, as well as A. wodanis and a few other members of the Vibrionaceae family. 
The strains were screened for the presence of NeuB coding sequences which were used to locate nab 
clusters in their genomes as well as study NeuB substrate specificity. Each cluster was analyzed in terms 
of gene content and organization, using sequence homology as a basis for functional annotation. From 
this, hypotheses pertaining to the nature of the NulO(s) produced by each strain could made. They were 
verified by analyzing the NulO content of the concerned organisms using mass spectrometry. 
 
Materials and Methods 
Bacterial strains and genome sequences 
The genome sequences for A. salmonicida LFI1238, M. viscosa 06/09/139 and A. wodanis 06/09/139 are 
published and were obtained from public databases [40, 41]. Sequences for the other Aliivibrio strains, 
as well as for the Photobacterium strain were provided by Espen Robertsen, via the MetaRep database 




[45]. They are available through the European Nucleotide Archive (ENA) under the PRJEB16014 study. 
The genome sequence for V. anguillarum NB10 was provided by Kåre Olav Holm [46]. The source 
information for the genomes used in this study is summarized in Table 1. 
The strains for this study were isolated from Eurythenes gryllus (Amphipoda) and Porifera indet [47]. 
Vibrio B9-25 was isolated from Halichondria sp. and P. phosphoreum SP005 was isolated from the gut of 
Onogadus argentatus. V. anguillarum NB10 was isolated from Gadhus morhua [48, 49]. 
 
Table 1. Bacterial sources of genome sequences. 
Organism Strain 
Aliivibrio salmonicida LFI12381, B9-25K22, MR17-772, R8-632, R8-682, R8-702 
Aliivibrio wodanis 06/09/1393 
Vibrio anguillarum NB104 
Photobacterium SP0052 
Moritella viscosa 06/09/1393, K585, K565, Vvi75, Vvi115, NVI54825, NVI49175, 
LFI50065, F575 
1 Accession numbers: NC_011310.1 to 011316.1 [41]. 
2 Obtained from the MetaRep database [42]. 





Genome analysis, nab cluster assignment, and sugar prediction 
The target genomes were, if necessary, annotated using the GePan pipeline of the Galaxy server at the 
University of Tromsø [50, 51]. Glimmer v3.2 was used for gene prediction and BLASTp for database 
search within Bacteria [52, 53]. 
The protein sequences for the NeuB homologs from A. salmonicida LFI1238 (accession numbers 
WP_012551408.1 and WP_012549051.1), M. viscosa 06/09/139 (WP_045111757.1 and 
WP_045111735.1), and A. wodanis 06/09/139 (WP_045100955.1) were used as query for a similarity 
search against the set of target genomes using the BLAST suite. [53]. Unique NeuB sequences were 





The positive NeuB hits were located on the target genomes and the surrounding area was investigated 
for the presence of putative nab gene clusters, using the Artemis software for viewing [56]. The cluster 
regions were determined by the gene content and direction of the relevant areas. Gene names were 
assigned according to protein sequence similarity to known nab genes, using the most comprehensive 
(to the authors) denominations. 
Identified clusters were analyzed for the function of each coding sequence composing them by 
performing sequence similarity searches within the non-redundant protein sequence database (BLAST) 
as well as domain searches within the Conserved domain Database [57]. 
 
Homology modelling of C. jejuni NeuB homologs 
The sequences for the NeuB homologs of C. jejuni NCTC11168 (WP_002858213.1, WP_002864265.1, 
and WP_002870258.1) were retrieved from public databases and used as targets for homology 
modelling using the NeuB homolog from N. meningitidis (PDB IDs: 1XUU, 1XUZ) as a template [58, 59]. 
The modelling was performed on the SWISS-MODEL server [60]. 
 
Nonulosonic content release and derivatization 
Cultures (15mL) of A. salmonicida LFI1238, M. viscosa 06/09/139, and Vibrio B9-25K2 were grown in 
liquid LB media containing 2.5% NaCl (48h, 12°C, 200 rpm). 3 mL pellets were harvested and washed 
with dH2O, before 0.1 µL phenylmethane sulfonyl fluoride (PMSF) was added. After a 15 minutes 
incubation on ice, 200 µL acetic acid (2M) and 2 µL butylated hydroxytoluene (BHT, 1%) was added. 
The samples were thereafter incubated for 3 hours at 80°C and spun down for 10 minutes at 13000 rpm. 
The supernatant was collected and filtered (Amicon 10K spin column) in order to remove large 
molecules. The filtrate was dried for 2 hours using a speed-vac, and the resulting samples were stored 
at -20°C until use. 
Samples were resuspended in 10 µL dH2O before performing the labelling reaction with 1,2-diamino-
4,5-methylenedioxybenzene (DMB, from TaKaRa) according to the manufacturer’s instructions [61-63]. 





Mass spectrometry analyses 
The quinoxaline (Q) content of the samples described in the previous section was analyzed by HPLC-
MS/MS using the procedure described by Gurung et al. [32]. Water with 0.1% formic acid (A) and 
acetonitrile with 0.1% formic acid (B) were used for the HPLC-MS elution gradient presented in Table 
2, at a flow rate of 400 µL/min. Tandem mass spectrometry was performed on samples containing 
compounds corresponding to masses equivalent to that of LegAmAcQ (m/z[M+H]+ = 450.19887323) 
and LegAc2Q/ PseAc2Q (m/z[M+H]+ = 451.1823402). The scan range was m/z 350-550. 
 
Table 2. Elution gradient for HPLC-MS 
Time (minutes) A (%) B (%) 
0 95 5 
1 95 5 
8 75 25 
8.01 10 90 
9 10 90 
9.01 95 5 
10 95 5 
 
 
Graphical output generation 
Gene clusters were rendered in SVG graphics using scripts written by the author. The scripts are 
available through the python-bioinformatics repository on GitHub [64]. Molecular structures were 






Results and discussion 
NeuB sequences comparison 
The two unique NeuB protein sequences from A. salmonicida LFI1238 (representing the Neu and Leg 
pathways) and M. viscosa (representing the Neu and Pse pathways), as well as the one from A. wodanis 
were used as queries for conducting a sequence similarity search within the set of target genomes, with 
the aim of detecting potential nab clusters. Out of the 15 targets, 10 had at least one sequence identical 
to one of the queries, and 3 had a similar sequence (an alignment of the unique NeuB sequences is 




Figure 1. Multiple alignment of unique NeuB sequences from Vibrionaceae. The sequences from A. salmonicida 
LFI1238, R8-63, and MR17-77 were aligned with that of M. viscosa and A. wodanis 06/09/139 as well as Vibrio B9-25K2. 
Residues putatively involved in substrate specificity are indicated by black circles. 
 
Six of the eight targeted M. viscosa strains have two NeuB coding sequences identical to the ones from 
the 06/09/139 strain. The two remaining strains contain each one sequence, identical to either the Neu-
pathway homolog (strain F57) or the Pse-pathway homolog (strain NVI-5482). This is consistent with 
the evolutionary relations between M. viscosa genomes according to which those two strains form their 
own clade [45]. For the Aliivibrio strains, two strains (R8-68 and R8-70) have sequences identical two 
both homologs from LFI1238. The MR17-77 and R8-63 strains each have one hit that is almost identical 




respectively. Again, this is in accordance with phylogenetic data [43, 44]. The NeuB sequence from Vibrio 
sp. B9-25K2 is most similar (54% sequence identity) to the M. viscosa Pse-pathway homolog. Closer 
sequences (above 80% identity) were found amongst Vibrionaceae, also coding for pseudaminic acid 
synthases (data not shown). 
The possibility of assigning NAB pathways solely based on the sequence of the NeuB homologs raises 
the question of what the determinants which discriminate between the pathways are. The genome of 
Campylobacter jejuni strains contain genes coding for NeuB variants for all three pathways and was 
therefore chosen for studying the pathway-related characteristics of NeuB homologs [68]. The NCTC 
11168 strain is able to produce Neu5Ac, Pse5Ac7Ac, and Leg5Ac7Ac, as well as derivatives of the 
Leg/Pse compounds (assuming that the acetamidino- derivatives are synthetized from the diacetylated 
compounds) [69]. Their sequences were modelled onto the structure of the NeuB homolog (Neu 
pathway) from Nesseria meningitidis (nmNeuB, PDB ID: 1XUU), and the structure of their active sites 
was compared with its PEP-bound form (PDB ID: 1XUZ) [58]. 
 
The results, presented in Figure2, show that while the active residues are strictly conserved between 
the Neu-pathway enzymes, they differ for the Leg- and Pse- pathway ones, as is expected. Indeed, the 
different pathways indicate that while NeuB from the Neu acts on ManNAc for the production of Neu5Ac, 
the substrates leading to diacetylated Pse and Leg compounds are 2,4-diacetamido-2,4,6-
trideoxyaltrose and 2,4-diacetamido-2,4,6-trideoxymannose, respectively [70-72]. Neither Leg nor Pse 
substrates carry a -OH group at C6, which explains the variations observed for residues N74 and M83 of 
nmNeuB. It is interesting to note that the OH group carried by C4 is interacting with a water molecule, 
which is probably not present in the cjNeuB2/cjNeuB3 active sites due to the N-acetyl group at this 
position, thus compensating for the additional bulk without changing the overall geometry of the active 
site. Its orientation is different in the Leg and Pse substrates (same orientation as the -OH of rMAnNAc 
for the Leg substrate), which justifies the different residues for cjNeuB2 and cjNeuB3 at this location. 
The F129 residue of cjNeuB3 is clashing with the N-acetyl group carried by C2, which makes sense since 





Figure 2. Comparison of NeuB active sites of C. jejuni and N. meningitidis. Green: NeuB from Nesseria meningitidis 
(1xuz). Ball and stick representations: reduced ManNAc (rMAnNAc, right) and phosphoenol pyruvate (PEP, left). Purple 
sphere: Mn2+. A: Neu pathway. Comparison with the model for NeuB1 of C. jejuni NCTC 11168. The carbon backbone of 
rManNAc is numbered, and the active site residues of N. meningitidis are indicated. B: Leg pathway. Comparison with the 
model for NeuB2 of C. jejuni NCTC 11168. C: Pse-pathway. Comparison with the model for NeuB3 of C. jejuni NCTC 
11168. For the Leg and Pse pathways, the C4 position of rManNAc (where there should be a second N-acetyl group) is 
indicated by an arrow. The C9 position, which does not carry a -OH group in Leg/Pse, is circled. Residues of NeuB2/NeuB3 
that differ from that of N. meningitidis are labeled. 
 
These results are also consistent with the proposed mechanism of NeuB enzymes, which depends on the 
area of the active site that houses PEP and the C1 of rMAnNAc. This area is conserved in all three 
isozymes, while the area binding the rest of the sugar molecule is less so, allowing for specificity at C2 
via position 133 (F129 in NeuB3) and at C4-C6 via the S2 loop and helix H4 (positions 70-85). These 
observations hold true for our set of sequences, were the corresponding residues (indicated by black 
circles in Figure ) clearly distinguish the Pse-pathway sequences from the other ones, notably at the 
position corresponding to that of F129 of cjNeuB3 from N. meningitidis, which is either occupied 




sequences from the Neu and Leg pathway (specificity at C4-C6) is less clear, with some of the concerned 
residues conserved across the pathways and/or distinct between the two Neu-pathway homologs. 
The same determinants may discriminate between isozymes from the same pathway but producing 
different sugars. The NeuB from A. salmonicida from the Neu pathway is thought to accept 4-acetylated 
ManNAc as a natural substrate rather than the monoacetylated form even though it is capable of utilizing 
it, which is consistent with the flexibility at the C4 position where the active site water molecule would 
compensate for the lack of NAc group [32]. Its other NeuB homolog is responsible for the synthesis of 
Leg [33]. The configuration at C4 for ManNAc2 would then be identical to that of LegAc2, since the 
substituents are in the same orientation, while C6 remains as it is in Neu5Ac, carrying an -OH group. In 
any case, it seems that A. salmonicida MR17-77 has the same specificity as A. salmonicida LFI1238, and 
A. salmonicida R8-63 as A. wodanis (the sequences they are closest to), since their sequences are 
identical within the putative specificity regions. In the case of the NeuB homologs from the Pse pathway, 
it is difficult to say if the differences within the “specificity region” are due to a different substrate and/or 
related to the bacterial species. 
 
nab cluster identification and analysis 
The genome regions surrounding each NeuB homolog hit were investigated for the presence of putative 
nab clusters. The results, presented in Figure 3, reveal that hits (or queries) with identical NeuB 
sequences had identical clusters (identical gene composition, sequences and organization). This is 
especially interesting in the case of the Leg pathway cluster from A. salmonicida LFI1238, where the 
pseudogene sequence for NeuA is conserved with that of A. salmonicida R8-68 and R8-70. Furthermore, 
where the NeuB sequences are not identical, the clusters are different, even if the sequences are highly 
similar. Indeed, the Leg clusters from A. salmonicida MR17-77 and R8-63, for which the NeuB sequences 
share 97% identity with that of A. salmonicida LFI1238 and A. wodanis, respectively, have a different 
architecture composed of different genes. When homologs are present, their sequences are similar, but 
not identical. It is worth noting that the Leg cluster of A. salmonicida R8-63 is closest to that of A. wodanis 
for its first part (up to the second aminotransferase), but then shows more similarity with that of A. 
salmonicida LFI1238 (PtmE and NeuA sequences). 
In order to confirm if this trend is observed for other species, we investigated the set of NeuB sequences 
similar to that of Vibrio B9-25K2, leading to the conclusion that when NeuB sequences are identical, the 
corresponding clusters might share a similar architecture with the same number of proteins coding for 







Figure 3. Unique nab clusters amongst Aliivibrio, Vibrio, and Moritella viscosa strains. The translated nucleotide 
sequence of each gene of each cluster was compared globally to the protein sequences coded by the nab clusters of A. 
salmonicida LFI1238, A. wodanis 06/09139, and M. viscosa 06/09/139. Each gene is colored according to the function of 
the encoded protein, as stated in the figure legend. The percentage of sequence identity between homologs is indicated 
by black arrows, with the value next to it. 
 
The cluster of Vibrio B9-25K2, for which the NeuB sequence was most similar to that of Pse pathway 
homolog from M. viscosa, contains homologs of sequences coding for PseB, PseC and PseG, which 
confirms its appartenance to this pathway. It also contains a homolog of PseH as a domain in a bi-
functional protein for which the second domain is of unknown function, but that is associated to lipid 
metabolism. A conserved domains analysis of the cluster coding sequences revealed that the bi-
functional enzyme encoded after PseC contains a putative cytidylyltransferase domain similar to the 
SpsF spore coat protein, indicating that it may be replacing the NeuA homolog absent from this cluster. 
The other coded domain is that of an aldo-keto reductase. Following this gene is a sequence coding for 
a dehydrogenase. The PseH homolog is followed by a gene coding for a hypothetical protein, with a 
domain similar to that of methylmalonyl CoA epimerase. The clusters corresponding to the closest NeuB 
sequences from public databases also contain the hypothetical protein and the bi-functional PseH 
homolog, both with around 60% sequence identity compared to that of Vibrio B9-25K2 (data not 
shown). A likewise search for the bi-functional cytidylyltransferase yielded a different set of strains 






From the analysis of the NeuB homologs, we were able to hypothetize that the NeuBs from  A. 
salmonicida MR17-77 and R8-63 most likely produces Leg compounds, with the one from MR17-77 
producing the same as that of A. salmonicida LFI1238 (LegAc2) and R8-63 the same as that of A. wodanis 
(LegAcAlaAc or similar, since the sugar in A. wodanis has not been identified yet).The NeuB from Vibrio 
B9-25K2 seems to produce a Pse related NulO, but the lack of close sequences with identified NulO 
content in the corresponding organisms prevented a more precise hypothesis. The results from the 
cluster analysis are in agreement with these suggestions, and they suggest that Vibrio B9-25K2 may 
produce a diacetylated Pse on account of the presence of a PseH homolog. The presence of enzymes of 
unknown function might indicate further modifications of produced compound. For the Aliivibrio strains 
with close NeuB sequences, they most likely ultimately produce different compounds since the 
composition of their clusters is not identical albeit NeuB homologs seemingly producing the same 
compound. 
 
Analysis of bacterial NulO content by LC-MS 
The NulO content of A. salmonicida LFI1238 and R8-63, M. viscosa and A. wodanis 06/09/139, and Vibrio 
sp. B9-25K2 was released by mild acid hydrolysis and labelled with DMB (A. salmonicida MR17-77 could 
not be grown at the time of the experiment). Separation of the quinoxalines by LC-MS led to the detection 
of several potential NulOs, as presented in Figure 4. As expected, the MS spectra for A. salmonicida 
LFI1238 contained peaks at masses corresponding to NeuAcQ (m/z = 426), NeuAc2Q (m/z = 468), and 
LegAmAcQ (m/z = 450). The M. viscosa sample showed peaks at masses corresponding to NeuAcQ, 
NeuAc2Q, and PseAc2Q (m/z = 451), with the latter also present in the Vibrio B9-25K2 sample but with 
a different retention time. The samples from A. salmonicida R8-63 and A. wodanis had peaks at m/z= 530 
and 522, respectively. While the former does not correspond to any identified NulO by this method, the 
latter can be assigned to the LegAcAlaAcQ compound observed in Vibrio vulnificus [39]. Those results 
verify the hypotheses made after analysis of the NeuB homologs and the nab clusters concerning the 
type of sugar produced by each cluster. A similar approach has already been used successfully in several 
species and the method appears robust, although it is limited to detecting compounds similar (by either 





Figure 4. LC-MS analysis of bacterial NulO content derivatized with DMB. Left: FTMS+ pESI full MS spectra. The 
spectra are represented for each species as a function of relative abundance versus retention time (in minutes). When 
several mass ranges are considered, the spectra are combined in a single graph using different colors for each curve (blue, 
pink, green, and orange). The mass range (m/z) corresponding to each peak is indicated next to it. Right: Mass spectra for 
the peaks from A. salmonicida R8-63 and A. wodanis. 
 
Tandem mass spectrometry 
While tandem mass spectrometry has been previously performed on the quinoxalinones of Neu 
compounds, no standards are available for Leg and Pse derivatives with the exception of LegAcAlaAc 
which was identified after this study was performed [32, 38, 39, 74]. MS/MS was therefore performed 
for peaks at masses corresponding to that of LegAmAcQ (m/z[M+H]+ = 450.19887323), and PseAc2Q 
(m/z[M+H]+ = 451.1823402). The LegAcAlaAcQ compound was not identified at the time of the 
experiment, and masses related to it were not investigated. The results, presented in Figure 5, show that 
the compounds from A. salmonicida (putative Leg5Am7Ac) and M. viscosa (putative Pse5Ac7Ac) share 
similar fragmentation patterns. Interestingly, the compound from Vibrio B9-25K2 has a different 
spectrum from that of M. viscosa, despite both corresponding to PseAc2. This suggests that either the 
position of the N-acetyl groups is different, or that some of the asymmetrical carbons have a different 
geometry, thus producing an epimer of Pse. No reports of a di-N-acetylated NulO carrying groups at 




the Leg pathway [11-14]. The determination of the absolute configuration of PseAc2 from Vibrio B9-
25K2, as well as studies targeting the proteins of its cluster should provide the necessary information. 
 
 
Figure 5. Mass spectrometry analysis of putative LegAcAm and PseAc2 compounds. A. Analysis for A. salmonicida 
LFI1238. Left: FTMS+ pESI full MS spectra at m/z= 450.1971-450.2007. Right: ITMS + cESI with full MS2 spectra of mass 
450.1989 at time 0.74-1.06 minutes. B. Analysis for M. viscosa 06/09/139. Left: FTMS+ pESI full MS spectra at m/z= 
451.1805-451.1841. Right: ITMS + cESI with full MS2 spectra of mass 451.1823 at time 3.38-3.56 minutes. C. Analysis 
for Vibrio B9-25K2. Left: FTMS+ pESI full MS spectra at m/z= 451.1805-451.1841. Right: ITMS + cESI with full MS2 spectra 
of mass 451.1823 at time 0.67-1.06 minutes. 
 
The parent ions for all compounds are either weak or absent, as is expected from molecules rich in 
alcohol groups. The base peak, at m/z = 415, can result from the loss of either two water molecules from 
the PseAc2 compounds or one water and one ammonia from LegAmAc. The fragmentation route 
proposed by Klein et al., which involves the formation of a ring between the C4 and C8 of the NulO 
moiety, is consistent with the observed peaks (see Figure 6). Indeed, the ring formation corresponds to 




peak is observed for Vibrio B9-25K2. This route leads, when the ring substituents are removed in C5-C7, 
to a compound with m/z= 297 which loses the ring to form the compound at m/z = 229. The compound 
from Vibrio B9-25K2 most likely forms another ring, due to a different proximity of the groups either 
because it is an epimer of Pse5Ac7Ac, and/or because the N-acetyl groups are carried by other positions. 
 
 
Figure 6. Proposed fragmentation route of LegAmAc (A. salmonicida) and PseAc2 (M. viscosa). The major peaks of 
the MS2 spectra (ITMS + cESI with full MS2) for both compounds were assigned to fragments of corresponding mass, 
according to the fragmentation route of Neu quinoxalines described by Klein et al. [74]. Multiple steps are marked with 






This study investigated the NulO content from a set of bacteria from the Vibrionaceae family, with an 
emphasis on A. salmonicida and M. viscosa. We showed that by comparing the sequences for their NeuB 
homologs, new nab clusters could be identified with non-identical NeuB sequences. We also determined 
substrate specificity regions, in particular a critical position occupied by either a glycine (Neu and Leg 
pathways) or a phenylalanine (Pse pathway) which discriminates between NAc orientation at the C2 
position of NeuB substrates. Further study of NeuB specificity not only opens for a better prediction of 
its substrates and products, but also the tailoring of already characterized enzymes for the production 
of various NulOs. 
Going further, the study of the nab clusters associated with NeuB sequences of interest allows for better 
hypotheses concerning NulO structure as well as the detection of new NAB proteins previously 
unidentified, such as the non-NeuA homolog cytidylyltransferase from Vibrio B9-25K2. Mass 
spectrometry analysis of the NulO content of the target organisms both confirmed the presence of 
predicted sugars, but also revealed a new compound in A. salmonicida R8-63 for which the 
corresponding quinoxaline has a m/z of 530, which awaits identification. 
Taken together, the results confirm that the methodology used in this paper is a robust approach for 
screening genomic data for NulO producing organisms and the identification of new protein and/or 
monosaccharide targets. In the case of Vibrio B9-25K2, which seems to produce a variant of PseAc2 with 
a different configuration and which cluster presents several unknown coding sequences, further studies 
might uncover a new branch of the Pse pathway. 
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Abstract 
Nostoc sp. strain KVJ20 was isolated near Kvaløya, in Northern Norway. This cyanobacterium has a 
broad symbiotic competence and extracts from the isolate has inhibitory effects on cancer cell lines 
and microbes. The genome further reveal many genes encoding the production of secondary 
metabolites, glycans and biotechnologically relevant enzymes. The strain is highly interesting both 
for fundamental and applied science. The genome is in total 9,183,495 bp (425 contigs/332 scaffolds) 
and contains 7,676 genes (7,210 protein coding & 104 RNA genes). The GC percentage is 41.69%. 
Comparing operons containing non-ribosomal peptide synthases and polyketide synthases (NRPS 
and PKS) from Nostoc sp. KVJ20 with those of Nostoc punctiforme PCC73102 reveal differences, 
which may shed more light on their involvement in symbiotic competence, cell differentiation and 
the self-cleaning observed when grown in vitro. 






Nostoc sp. strain KVJ20 was isolated from the symbiotic organs of the liverwort Blasia pusilla L. 
found as a weed in a plant-school on the island of Kvaløya, Northern Norway. During the isolation 
process, we noted that the strain was unusually clean from the first steps of cultivation, and did not 
require additional treatments for bringing it into an axenic state. This was an indication that the 
organism may produce antibiotic compounds serving the function of self-cleaning. We had a similar 
experience with genetically similar Nostoc sp SKSF3 originated from soil. Metabolic profiling by 
MALDi-TOF showed similarity between the secondary metabolites sets produced by these two 
isolates (Liaimer, et al. 2016). In addition, the cell extracts of Nostoc sp. KVJ20 showed inhibitory 
effects on A2068 metastatic human melanoma cell line and MRC5 fibroblasts (Liaimer, et al. 2016). 
The insight into metabolic capacities of the strain, based on full genome sequencing, may therefore 
help in explaining antimicrobial and anticancer properties of this cyanobacterium. 
In addition to its ability to exist in symbiosis with its natural liverwort host, Nostoc sp. KVJ20 
successfully infected seedlings of angiosperm Gunnera manicata Linden, where it was housed 
intracellularly. The host plant, G.manicata Linden is a native of South America, and has no history 
of being grown above the Arctic Circle. Up to date, most of the genomes available in the databases 
for genus Nostoc represent free-living isolates. The only strain with equally broad symbiotic 
competence, whose genome is available, is Nostoc punctiforme PCC73102 (Ekman, et al. 2013). The 
traits responsible for symbiotic interactions between nitrogen fixing cyanobacteria and plants remain 
unknown. Thus, the genome of Nostoc sp. KVJ20 will add valuable information on the core features 
underlying symbiotic capacity in the genus.  The observations on the bioactivities of Nostoc sp. 
KVJ20 and the broad symbiotic competence were therefore major reasons for choosing the strain for 
full genome sequencing. 
The Nostoc genus represents a group of filamentous, nitrogen fixing, photosynthetic 
cyanobacteria. They are able to produce the four different cell types known to the phylum, and can 
be found as either independent colonies or endosymbionts in some plants. The formation and 
composition of filaments, as well as the symbiotic association, are highly dependent on cell 
differentiation, and several genes have been identified to play a significant role in those processes 
(Chapman, et al. 2008; Flores 2012; Meeks and Elhai 2002). Such genes can be identified by their 
ability to code for secondary metabolites specific to some cyanobacteria genera. One secondary 




differentiation of the hormogonium cell type in Nostoc punctiforme (Liaimer et al 2015). It is 
synthetized by the proteins of the nos gene cluster, which codes for a series of non-ribosomal peptide 
and polyketide synthases (NRPS and PKS). Similar clusters encode other secondary metabolites. The 
identification of genes coding for NRPSs and PKSs within the Nostoc sp. KVJ20 genome is one of 
our interests. Additionally, Cyanobacteria produce a variety of glycans and glycan modifying 
enzymes (Kehr and Dittmann 2015). These glycans can also have anti-cancer activity (Guo, et al. 
2015) and the glycan modifying enzymes are of biotechnological interest. 
 
Materials and Methods 
Strain Isolation and DNA purification 
The isolation of Nostoc sp. KVJ20 from the symbiotic organs of the liverwort Blasia pusilla was 
carried out as described earlier (West and Adams 1997). The strain is maintained at Department of 
Arctic and Marine Biology, Faculty of Biosciences, Fisheries and Economics, UiT The Arctic 
University of Norway. Genomic DNA from cultured Nostoc sp. KVJ20 were purified according to a 
published protocol with the modifications suggested by the group of Prof. John C. Meeks, University 
of California (http://microbiology.ucdavis.edu/meeks/xpro5.htm), (supplementary text 1). 
Genome Sequencing, Assembly and Annotation 
A Qubit Fluorometer (Thermo Fisher) together with the Qubit dsDNA High sensitivity kit was used 
for accurate DNA concentration measurements. For the library, Nextera DNA Library Prep kit was 
used. A Bioanalyzer (Agilent Technologies) was used together with Agilent High sensitivity DNA 
kit for fragment size assessment. The library was sequenced on a MiSeq machine (Illumina) at UiT 
The Artic University of Norway, using MiSeq reagents kit V3, 2 x 300 bp. Using CLC Genomics 
Workbench (QIAGEN), the reads were trimmed to remove remaining sequencing adaptors and 
indexes. Also, the 10 first nucleotides and the 20 last of each read were masked. All reads with more 
than 20 undetermined bases were discarded. Sequence areas with lower q-score than 20 were 
removed.  9,259,128 reads with an average read length of 208 bases were thereafter assembled. After 
manual inspection, eight low coverage contigs belonging to Methylobacterium sp. were discarded. 
The NCBI Prokaryotic Genome Annotation Pipeline was used for annotation, with GeneMarkS+ for 




ncRNAs and repeat regions were annotated. The Whole Genome Shotgun (WGS) sequence is 
deposited in GenBank under accession number ERP003528. 
Phylogenetic Tree, Secondary Metabolites and Gene Order 
A phylogenetic tree based on aligned 16s rRNA genes, aligned using MUSCLE (Edgar 2004a, b) was 
used as input to the web-server “Phylogeny.fr” (Dereeper, et al. 2010; Dereeper, et al. 2008). A total 
of 1402 positions, not including gaps, was compared and used to reconstruct and analyze the 
phylogenetic relationships. By using the antiSMASH database and analyses tool (Weber, et al. 2015), 
complemented by additional Blast analyses (Altschul, et al. 1990), gene-clusters/operons coding 
genes involved in biosynthesis of NRPS, PKS, hybrid NRPS-PKS products as well as ribosomally 
synthesized and post-translationally modified peptides (RiPP) were predicted. To aid in visualization, 
a Python-script for creating vector-images of gene clusters was written. The script can be found at 
github (https://github.com/mariejhh/python-bioinformatics/wiki/GeneSVG). 
 
Results and Discussion 
Strain Phylogeny and Characteristics 
The strain was remarkable clean after the first culturing and no special procedures had to be conducted 
in order to get the strain axenic. This is in strong contrast to what is expected when isolating 
cyanobacteria as bacterial contaminants are hard to avoid (Waterbury 2006). 
Photos of Nostoc sp. KVJ20 at different life stages and the placement of Nostoc sp. KVJ20 relative 
to other strains within the Nostocaceae family is presented in Figure 1. By comparing the gene 
encoding 16s rRNA of several cyanobacteria with that of Nostoc sp. KVJ20 we found that the closest 





Figure 1. Nostoc sp. KVJ20 at different life stages. (A) diazotrophically grown Nostoc sp. KVJ20 at exponential stage, 
with vegetative cells arranged in multicellular filaments interspersed by nitrogen-fixing cells- heterocysts. (B) motile 
filaments, hormogonia. (C) a filament differentiating resting cells, akinetes, and (D) mature resting cells, akinetes. The bar 
is 10 µM. (E) Phylogenetic tree highlighting the position of Nostoc sp. KVJ20 (in bold) relative to other strains within the 
Nostocaceae family. Strains names marked with an asterix (*) have been genome sequenced. The strains and their 
corresponding GenBank accession numbers for 16S rRNA genes are: Nostoc sp. KVJ20, LSSA00000000; Nostoc 
punctiforme PCC73102, AF027655.1; Nostoc calcicola III, AJ630447.1; Nostoc edaphicum X, AJ630449.1; Desmonostoc 
sp. PCC6302, HG004582.1; Cylindrospermum stagnale PCC7417, AJ133163.1; Nostoc sp. PCC7120, 
BA000019:2375734-2377222; Aphanizomenon flos-aquae 1tu26s2, AJ630443.1; Nodularia spumigena PCC73104, 
DQ185241.1. Confidence index values are shown in red and the bar represents the amount of nucleotide substitutions per 






The draft genome is composed of 425 contigs (332 scaffolds), giving a total size of 9,183,495 bp. 
After annotation, 4,443 genes were assigned to functional COG categories (Tatusov, et al. 2000). The 
properties and the statistics of the genome are summarized in Table 1. 
Table 1. Properties and statistics of the Nostoc sp. KVJ20 genome. 
Attribute Value % of Total 
Genome size (bp) 9,183,495 100 
DNA coding (bp) 7,004,057 76.27 
DNA G+C (bp) 3,828,869 41.69 
DNA scaffolds 332 100 
Total genes 7,676 100 
Protein coding genes 7,210 93.93 
RNA genes 104 1.35 
Pseudo genes 362 4.72 
Genes assigned to COGs 4,443 57.88 
CRISPR repeats 12 - 
Coverage (x) 200 - 
 
The fragmented nature of the genome suggests a high number of repeat sequences and transposable 
elements, which would make the assembly difficult. From the initial annotation, 70 sequences were 
found to code for transposases, 22 for integrases, and 12 CRISPR repeat regions were assigned. The 
presence of tandem repeats was investigated in each contig using Tandem Repeats Finder version 
4.09 (Benson 1999). A total of 2,869 repeats were found in 298 contigs. In comparison, the genome 
of Nostoc punctiforme PCC 73102 contain 1,476 tandem repeats. 
 
Secondary Metabolite Gene Clusters 
Secondary metabolites are coded by NRPSs and PKSs. Originally 24 genes were annotated as coding 
for a NRPS or PKS, located on 10 different contigs. The translated sequences for these targets, as 




protein database of NCBI. From this, gene clusters were identified (see Supplemental Table 1). The 
suggested product(s) of the clusters is a mixture of both known and putatively unknown novel 
compounds. They encode amongs other lantipeptides, microviridins, nostocyclopeptide and 
aeruginosin/banyaside (supplemental figure 1). Some of the secondary metabolites produced could 
be potent antimicrobial substances, which would explain the self-cleaning properties when culturing 
this strain. 
The genome of the Nostoc sp. KVJ20 bacterium represents an interesting addition to the 
increasing number of sequenced cyanobacteria. Its symbiotic competence, the self-cleaning ability, 
the cellular differentiation mechanism and how these properties are connected to production of 
secondary metabolites from the identified gene clusters will be interesting to pursue further. 
 
Supplementary Material 
Supplementary data is presented after the references for this manuscript. 
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Supplementary Table 1. Summary of the predicted gene-clusters/operons coding genes involved in 
biosynthesis of non-ribosomally synthesised peptides (NRPS), polyketides (PKS), hybrid NRPS-
PKS products as well as ribosomally synthesized and post-translationally modified peptides (RiPP). 
*Predictions are made based on data presented in (Liaimer et al. 2016). abcThese clusters are 
























RiPP LSSA01000061.1 A4S05_28035- 
A4S05_28095 
bacteriocins  
RiPP LSSA01000098.1 A4S05_30035- 
A4S05_30055 
bacteriocins  

















PKS LSSA01000165.1 A4S05_34290- 
A4S05_34320 




RiPP LSSA01000173.1 A4S05_34670- 
A4S05_34700 
bacteriocins  







PKS LSSA01000184.1 A4S05_35385- 
A4S05_35455 






















bacteriocins. unknown  
RiPP LSSA01000345.1 A4S05_10295- 
A4S05_10310 
bacteriocins  
RiPP LSSA01000352.1 A4S05_10950- 
A4S05_11010 
bacteriocins  
RiPP LSSA01000386.1 A4S05_14495- 
A4S05_14560 
lantipeptides  
RiPP LSSA01000401.1 A4S05_16960- 
A4S05_17015 
bacteriocins  
NRPS LSSA01000425.1 A4S05_02060- 
A4S05_02085 










Supplementary Figure 1. Graphical representation of gene organization of secondary metabolites encoding clusters containing non-ribosomal 
peptide synthetases (NRPS, blue color)) and/or ribosomally synthesized and post-translationally modified peptides (RiPP, red color). Transporter 
genes are marked in yellow, hypothetical genes in gray and other functions are left white. Accession numbers are in bold font. (A) lantipeptides, 










Genomic DNA Isolation Procedure for Nostoc punctiforme    5/2000 
 
This procedure should yield high molecular weight (greater than 50 kb) genomic DNA that is clean enough for 





TE (10 mM Tris + 1mM EDTA, pH=8) 
Lysozyme (20 mg/ml in TE, make up fresh) 
0.5M EDTA, pH=8 
20% SDS 
Proteinase K (2 mg/ml in TE, make up fresh) 
CTAB solution (10% CTAB + 0.7 M NaCl) 
Phenol:chloroform (1:1, v/v) 
Chloroform 






1. Pellet the culture by centrifuging at 1,000 x g (maximum rpm in clinacial centrifuge) for 5 min in a 15 or 50 ml 
plastic centrifuge tube. As much as 600 ug of Chl a (~ 6 x 108 cells) may be processed at one time. 
2. Wash the pellet twice with 5M NaCl for removal of polysaccharides. 
3. Resuspend by vortexing the pellet in 1.0 ml total volume with TE. 
4. Add 1.0 ml of lysozyme solution. Invert gently, then incubate at 37C for one hour. Invert periodically 
duringincubation. 
5. Add 0.5 ml of 0.5 M EDTA. 
6. Add 1.0 ml of proteinase K solution and 100 ul of 20 % SDS. Invert gently to mix. Incubate at 37C for an hour, 
inverting gently several times during incubation. 
7. Add 1/6 x vol (600 ul) of 5M NaCl, mix. 
8. Add 1/8 x vol (450 ul) of CTAB solution, mix. Heat to 65C for 10 min. 
9. Pellet the cell debris by centrifugation at 13, 000 x g for 5 min at room temperature. Decant the supernatant 
gently into a new tube. Be careful to avoid the disk of cell debris that sometimes forms on top of the liquid. 
Be sure the centrifuge is at room temperature and not cooled, as DNA will pellet at cooler temperatures as 
well. 
10. Extract once with chloroform. Transfer aqueous phase to a new tube. 
11. Precipitate the DNA with 2 x vol of 95% ethanol. Stringy DNA molecules should be macroscopically visible at 
this point. Pellet at 13,000 x g for 5 min. 
12. Dissolve DNA pellet with 500 ml of TE and transfer to a microfuge tube. Extract with an equal volume of 
phenol:chloroform. Repeat extractions until the interface is clear. For highest yields of DNA back extract all 
organic phases. 
13. Precipitate DNA by adding 1/10 x vol of 3 M sodium acetate and 2 x vol of 95% ethanol. Wash the pellet with 
70% ethanol. 
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The crystal structure of the N-acetylglucosamine
2-epimerase from Nostoc sp. KVJ10 reveals the true
dimer
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N-Acetylglucosamine 2-epimerases (AGEs) catalyze the interconversion of
N-acetylglucosamine and N-acetylmannosamine. They can be used to perform
the first step in the synthesis of sialic acid from N-acetylglucosamine, which
makes the need for efficient AGEs a priority. This study presents the structure of
the AGE from Nostoc sp. KVJ10 collected in northern Norway, referred to as
nAGE10. It is the third AGE structure to be published to date, and the first one
in space group P42212. The nAGE10 monomer folds as an (/)6 barrel in a
similar manner to that of the previously published AGEs, but the crystal did not
contain the dimers that have previously been reported. The previously proposed
‘back-to-back’ assembly involved the face of the AGE monomer where the
barrel helices are connected by small loops. Instead, a ‘front-to-front’ dimer was
found in nAGE10 involving the long loops that connect the barrel helices at this
end. This assembly is also present in the other AGE structures, but was
attributed to crystal packing, even though the ‘front’ interface areas are larger
and are more conserved than the ‘back’ interface areas. In addition, the front-to-
front association allows a better explanation of the previously reported
observations considering surface cysteines. Together, these results indicate that
the ‘front-to-front’ dimer is the most probable biological assembly for AGEs.
1. Introduction
N-Acetylglucosamine 2-epimerases (AGEs; EC 5.1.3.8) cata-
lyze the reversible epimerization of N-acetylmannosamine
(ManNAc) to N-acetylglucosamine (GlcNAc) in both
eukaryotic and prokaryotic cells (Ghosh & Roseman, 1965;
Lee, Chien et al., 2007). It seems that their role, at least in
mammals, is to divert the metabolic flux away from sialic acid
synthesis (Luchansky et al., 2003). The reaction follows a
deprotonation/reprotonation mechanism involving two key
residues, which had been thought to be histidines, but which
have recently been identified as a glutamine and an arginine
(Lee, Wu et al., 2007; Takahashi, Takahashi et al., 2001; Wang et
al., 2016). AGE activity is greatly enhanced by the presence of
nucleotides, in particular ATP, which serve as allosteric acti-
vators (Datta, 1970; Ghosh & Roseman, 1965; Tabata et al.,
2002; Takahashi, Hori et al., 2001).
From an industrial point of view, AGEs can be used for the
synthesis of N-acetylneuraminic acid (Neu5Ac), which is also
known as sialic acid (Hu et al., 2010; Kragl et al., 1991; Lee et
al., 2004; Lee, Chien et al., 2007; Maru et al., 1996; Tabata et al.,
2002; Wang et al., 2009). One current approach is a one-pot,
coupled reaction with an N-acetylneuraminic acid lyase (NAL;
EC 4.1.3.3), in which the AGE performs the (reverse)
GlcNAc-to-ManNAc epimerization and the NAL performs
ISSN 2059-7983
the condensation with pyruvate, thus producing Neu5Ac.
However, there are several challenges related to the use of
AGEs in this step, such as the unfavourable thermodynamic
equilibrium, the requirement for ATP and the inhibition by
both pyruvate and Neu5Ac (Datta, 1970; Ghosh & Roseman,
1965; Klermund et al., 2013; Kragl et al., 1991).
In order to optimize Neu5Ac production, the search for
better AGEs is a current area of focus and enzymes from
cyanobacterial sources seem to be the most promising. Indeed,
the AGEs from Anabaena sp. CH1 (AnaAGE) and A. varia-
bilis ATCC 29413 (AvaAGE) have a specific activity that is
almost four times that of the porcine enzyme, despite having
similar affinities for GlcNAc (Klermund et al., 2013; Lee, Wu et
al., 2007). Other enzymes present interesting properties, such
as the AGE from Bacteroides ovatus ATCC 8483 (BoAGE),
which shows a much higher affinity for GlcNAc than ManNAc,
and that from Synechocystis PCC 6803 (SynAGE), which has
the lowest Km values for both GlcNAc and ManNAc of all
AGEs that have been characterized to date (Sola-Carvajal et
al., 2012; Tabata et al., 2002).
In addition to bioprospecting for enzymes that are more
suited for industrial purposes, the identification of the struc-
tural elements that govern the activity parameters of AGEs is
a priority. Two AGEs had been crystallized prior to this study:
the porcine enzyme (pAGE; PDB entry 1fp3) and that from
Anabaena sp. CH1 (AnaAGE; PDB entry 2gz6), the latter of
which used the former as a template for molecular replace-
ment (Itoh et al., 2000; Lee, Wu et al., 2007). These studies
revealed that the overall structure of AGEs is that of a (/)6
barrel. Together with mutagenesis studies, this led to the
proposal of a reaction mechanism involving two critical
histidine residues as acid/base catalysts in the protonation/
deprotonation of carbon C2 of GlcNAc/ManNAc. The enzyme
from Pedobacter heparinus DSM2366 (PhGn2E) was used in a
hydrogen/deuterium-exchange experiment, which confirmed
this type of mechanism for the epimerization, albeit with a
glutamine/arginine pair as catalysts (Wang et al., 2016).
AGEs were found to be structurally similar to sulfoquino-
vose isomerases encoded by the yihS gene (EC 5.3.1.31) and to
cellobiose 2-epimerases (CE; EC 5.1.3.11), despite a relatively
low sequence identity (Denger et al., 2014; Fujiwara et al.,
2013, 2014; Itoh et al., 2008; Tyler & Leatherwood, 1967).
Together, they form the AGE superfamily (Pfam accession
No. PF07221), for which 13 structures are currently available
(Bateman et al., 2004; Finn et al., 2014). Several of these
structures have been solved as protein–ligand complexes, and
structural comparison of the relatively conserved active sites
helped to form the current hypothesis for the catalytic
mechanism of AGEs (Itoh et al., 2008).
In this study, we report the determination of the crystal
structure of the AGE from the local strain Nostoc sp. KVJ10,
which we refer to as nAGE10 (Liaimer et al., 2016). We also
demonstrate that the most probable biological assembly for
the AGE dimer involves the opposite face of the barrel to that
published previously. Finally, we reveal the presence of a
putatively conserved chloride ion within the active site of
AGE.
2. Materials and methods
2.1. Cloning, expression and purification
The gene coding for nAGE10, containing the coding
sequence for a C-terminal hexahistidine tag and optimized for
expression in Escherichia coli, was synthesized by GeneArt
and subcloned into the pDEST14 expression vector using the
Gateway cloning system (ThermoFisher Scientific). The
protein was expressed in E. coli BL21 Star (DE3) cells
(ThermoFisher Scientific), which were grown at 37C to an
OD600 of 0.6, brought to 20
C and induced with 0.5 mM
isopropyl -d-1-thiogalactopyranoside (IPTG; Sigma–
Aldrich). The cells were incubated for approximately 16 h at
20C and harvested by centrifugation at 6000g for 25 min.
Bacterial cell pellets were resuspended in 50 mM Tris–HCl pH
7.5, 250 mM NaCl, 5 mM -mercaptoethanol, 10 mM imida-
zole, along with half a tablet of protease-inhibitor cocktail
(Roche) and 2 ml DNAse I. The cells were disrupted using a
French press and the extract was centrifuged at 20 000g for
2  30 min to remove cell debris. The supernatant was filtered
and purified by affinity chromatography using a 5 ml HisTrap
column (GE Healthcare). The binding buffer consisted of
20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 20 mM
imidazole. The elution buffer consisted of 20 mM sodium
phosphate pH 7.4, 0.5 M NaCl, 500 mM imidazole. The protein
was eluted using a gradient from 5% to 80% elution buffer
over 60 ml. After purification, fractions containing protein
were assessed by SDS–PAGE. Pure fractions were pooled and
dialyzed overnight in 50 mM Tris–HCl pH 7.5, 250 mM NaCl.
The protein solutions were further dialyzed into storage buffer
(20 mM HEPES pH 7.4, 115 mM NaCl). The oligomerization
state of nAGE10 was determined by gel-filtration chromato-
graphy on a Superdex 75 10/300 GL column (GE Healthcare).
The results are presented in the supporting information. The
protein concentration was determined by measuring the
absorbance at 280 nm using a theoretical extinction coefficient
for the protein.
2.2. Differential scanning calorimetry
Differential scanning calorimetry (DSC) was used to
determine the melting temperature of nAGE10. Thermal
denaturation of nAGE10 was followed between 5 and 95C
using a heating/cooling rate of 1C min1. A solution of
nAGE10 at 1.5 mg ml1 in storage buffer was used in the
experiment. The results are presented in the supporting
information.
2.3. Structure determination
The protein was concentrated to 10 mg ml1 in storage
buffer prior to crystallization. Screening for crystallization
conditions was performed using the sitting-drop method (drop
size of 200 + 200 nl). The initial screening was performed using
in-house and commercially available screens at both room
temperature and 4C. From this, two initial hits were obtained
(at both temperatures) with 0.1 M sodium acetate pH 5, 17.6%
PEG 6000 or with a combination of 0.07 M sodium acetate
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pH 5, 0.05 M calcium acetate and 12% PEG 3350. The opti-
mized crystallization condition was 0.1 M sodium acetate pH
5, 0.1 M calcium acetate, 10% PEG 3350, 3% dextran. Crystals
were obtained at room temperature after 1–3 days of incu-
bation and were flash-cooled in liquid nitrogen. 20% ethylene
glycol was used as a cryoprotectant. Crystallographic data
were collected at the BESSY II photon source, Helmholtz-
Zentrum Berlin, Germany. The images were integrated using
XDSapp (Sparta et al., 2016). The structure was solved by
molecular replacement using the AnaAGE structure (PDB
entry 2gz6) as a search model (Lee, Wu et al., 2007). Refine-
ment was performed using PHENIX and the CCP4 program
REFMAC5 (Adams et al., 2010; Murshudov et al., 2011; Winn
et al., 2011). The waters were placed by Coot v.0.7.2 (Emsley et
al., 2010). The crystallographic data and model statistics are
summarized in Table 1.
2.4. Analysis of interface areas
The surfaces of nAGE10, AnaAGE and pAGE were
analyzed using the PDBePISA server in order to obtain
parameters pertaining to the structural and chemical proper-
ties of possible assemblies (Krissinel & Henrick, 2007).
2.5. Sequence comparison
The amino-acid sequence of nAGE10 and the previously
characterized AGEs were aligned using the MUSCLE
multiple sequence alignment tool with default settings (Edgar,
2004a,b). Secondary-structure data for nAGE10 and pAGE
were obtained from their respective PDB files. The graphical
output was created using the TeXshade package for LaTeX
(Beitz, 2000).
2.6. Enzyme-activity measurement
The activity of nAGE10 was assessed by coupling the
epimerization to the condensation reaction catalyzed by the
NAL from Aliivibrio salmonicida (AsNAL; EC 4.1.3.3; PDB
entry 5afd; M. K. Gurung, B. Altermark, I. L. U. Rader, R.
Helland & A. O. Smalas, unpublished work), resulting in the
production of Neu5Ac. Its presence was detected using the
thiobarbituric acid (TBA) assay (Warren, 1959). Samples
consisting of 124 mM HEPES pH 8.0, either 15 mM GlcNAc
or 15 mM ManNAc, 10 mM ATP, 15 mM pyruvate, 7 mg NAL
and 10 mg AGE10 were incubated at room temperature for
1 h. The reactions were terminated by adding 137 ml sodium
periodate (2.5 mg ml1 sodium periodate in 57 mM H2SO4)
followed by incubation at 37C for 15 min with shaking.
Arsenite solution (50 ml, 25 mg ml1 in 0.5 M HCl) was added,
resulting in a brown colour. The tubes were shaken until
the brown colour disappeared and 100 ml TBA solution
(71 mg ml1 TBA pH 9.0) was then added. The samples were
placed in boiling water for 7.5 min and then on ice for 5 min;
they were then brought to room temperature for 5 min. Acidic
n-butanol (5% HCl, 1 ml) was added and the samples were
shaken for 10 min at room temperature. The tubes were spun
down at 16 060g for 7 min and the absorbance of the upper
layer was measured at 549 nm on a SpectraMax (Molecular
Devices). A molar extinction coefficient of 57 000 M 1 cm1
was used for concentration calculations (Warren, 1959).
2.7. Graphical output generation
Molecular representations were generated using PyMOL
(v.1.8; Schrödinger) and sequence alignments were rendered
with the TeXshade package for LaTeX (Beitz, 2000). Figure
editing was performed in Inkscape (https://inkscape.org/).
3. Results and discussion
3.1. Structure of nAGE10
nAGE10 was crystallized using the hanging-drop vapour-
diffusion method. Just as for pAGE (PDB entry 1fp3) and
AnaAGE (PDB entry 2gz6), nAGE10 crystallized at a pH
below 6. Attempts to either crystallize it at a higher pH or to
increase the pH of the existing crystals were unsuccessful. Co-
crystallization trials with GlcNAc, ManNAc or ATP, as well as
a combination of the latter with hexosamine, did not result in
crystallized complexes, although crystals of the apoenzyme
were obtained from these experiments. Soaking did not affect
the crystals. These results are similar to those described for
previously published AGE structures, indicating that this
behaviour may be inherent to AGEs rather than to the crys-
tallization method. Temperature did not seem to play a
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Table 1
Data collection and processing.
Values in parentheses are for the outer shell.
PDB code 6f04
Data collection
Synchrotron-radiation source BESSY 14.1
Detector PILATUS 6M
Wavelength (Å) 0.9184
No. of frames 1800
Oscillation range per frame () 0.1
Diffraction data
Space group P42212
a, b, c (Å) 142.423, 142.423, 52.046
Protein molecules in asymmetric unit 1
Total No. of reflections 768654 (109502)
No. of unique reflections 59456 (9464)
Resolution range (Å) 50–1.7 (1.8–1.7)
Completeness (%) 99.9 (99.7)
hI/(I)i 15.58 (1.49)
Observed R factor (%) 13.2 (143)
CC1/2 99.9 (64.3)
Refinement
Resolution limits (Å) 48.9–1.7
No. of used reflections 59447
Data completeness (%) 99.94
Percentage of free reflections 3.5
No. of protein atoms 3214
No. of heterogen atoms 17
No. of waters 318
R factor/Rfree 0.179/0.209
Overall B factor from Wilson plot (Å2) 21.61
R.m.s.d., bonds (Å) 0.007





significant role in the crystallization process, as similar crystals
were obtained at both room temperature and 4C.
The nAGE10 crystal diffracted to 1.70 Å resolution, and
the subsequent model, which was determined by molecular
replacement using the AnaAGE structure (PDB entry 2gz6;
90% sequence identity), was refined to an R factor of 0.179
(Rfree = 0.209). The r.m.s.d. between the two structures is 0.8
(Holm & Laakso, 2016). The refinement data are summarized
in Table 1. In contrast to the pAGE and AnaAGE crystals,
which both belonged to space group P212121, the nAGE10
crystal belonged to space group P42212.
The asymmetric unit contained one nAGE10 monomer, a
chloride ion and three ethylene glycol molecules, as well as 318
waters (Fig. 1a). The structure of the monomer was resolved
for the amino-acid sequence from Tyr3 to Leu391, with resi-
dues 157–164 missing. The fold is that of an (/)6 barrel, with
the helices connected by small loops at one end (the back) and
long loops at the other end (the front). The nAGE10 barrel is
composed of two concentric rings of six helices each, in which
the sequence orientation is opposite. Helices H1, H3, H5, H7,
H9 and H11 form the outer ring of the barrel, with the even-
numbered helices as the inner ring (Fig. 1b). The nAGE10
barrel is about 50 Å in diameter and 30 Å in length.
3.2. Dimer assembly
Fig. 1(c) shows nAGE10 as a dimer, which was generated by
twofold symmetry using the operation y  1, x + 1, z. The
calculated interaction interface
represents 9.1% of the accessible
surface area, but this value is
most likely to be underestimated
owing to the disordered loop
between residues 156 and 165
(indicated by red arrows in
Fig. 1c). The interface is
composed of 41 residues for each
monomer, 35 of which participate
in extensive interactions (Table
2). 11 hydrogen bonds involve
the residue pairs Asp48/Arg234,
Asp50/Arg167, Pro108/Thr166
(which only occurs once),
Gln295/Lys367, Leu297/Gln301
and Trp299/Leu360. In addition,
53 pairs of residues form van der
Waals (vdW) interactions. The
proposed interactions involving
residues Thr166 and Arg167 are
probably influenced by the
disorder of the aforementioned
loop.
The nAGE10 dimer, which
involves the front faces of each
monomer, differs from the back-
to-back association presented for
AnaAGE and pAGE (Itoh et al.,
2000; Lee, Wu et al., 2007). A
front-to-front association for
AnaAGE (symmetry operator x
1, y, z) is mentioned by Lee et al.
(2007) and is attributed to crystal
packing. However, the nAGE10
dimer can be superimposed onto
that of AnaAGE assuming that
the front-to-front packing in PDB
entry 2gz6 is the biological dimer
(instead of the back-to-back
packing). pAGE, which has the
same crystal packing as AnaAGE,
also has a front-to-front dimer
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Figure 1
Structural overview of nAGE10. (a) The contents of the asymmetric unit of the nAGE10 structure, with the
nAGE10 monomer shown from the side in a cartoon representation. It is coloured using a green–blue
palette from the N-terminal to the C-terminal residues. Waters are shown as red, nonbonded spheres.
Ethylene glycol molecules (three) are represented as yellow sticks and the buried chloride ion as a green
sphere. (b) The nAGE10 monomer, shown from the front (the face where the -helices that form the barrel
are linked by short loops). Each helix is numbered (H1–H12) according to its placement in the amino-acid
sequence. (c) The nAGE10 dimer. Generation of symmetry mates within 3 Å of nAGE10 reveals the
presence of an additional monomer for which dimer association is probable involving the fronts of the
monomers. Red arrows indicate the extremities of the disordered loop (residues 156–165).
(Fig. 2). A comparison of the unit cell of nAGE10 with those
of pAGE and AnaAGE reveals not only that the back-to-back
assembly does not exist in the nAGE10 crystal, but also that
either the front-to-front or the back-to-back assemblies can be
used as the asymmetric unit for the pAGE and AnaAGE
structures, as presented in Fig. 2.
A comparison of the assembly parameters calculated by the
PISA method indicates that the front-to-front organization is
more favourable than the back-to-back organization in terms
of interface area, number of interactions and solvation energy
(Krissinel & Henrick, 2007). For AnaAGE, the interface area
is only 346.8 Å2 for the back-to-back assembly, while it is
1386.3 Å2 for the front-to-front complex (again, the missing
residues may be part of the dimer interface, so the interface
area for the front-to-front assembly is probably larger). The
two interfaces of pAGE have similar areas (1227.2 Å2 for the
front and 1029 Å2 for the back), but the solvation energy is
much more favourable for the front-to-front assembly at
22.3 kcal mol1, compared with 1.2 kcal mol1 for the
back-to-back assembly. In terms of interactions, Itoh et al.
(2000) reported that nine hydrogen bonds and 23 vdW
contacts (<4.5 Å) occur between monomers in the back-to-
back assembly. Using the same criteria, 13 hydrogen bonds
and 52 vdW contacts can be found for the front-to-front dimer
(Table 2). In the case of AnaAGE the front-to-front assembly
is mentioned (as crystal packing), but only the interactions
involving eight residues are described. Using the same criteria
as the authors for identifying interactions and considering only
hydrogen bonds leads to the involvement of 14 residues
(Table 2). For example, the residues involved in the polar
interactions that take place between Asp49 and Arg166,
between Pro107 and Thr165 and between Trp298 and Leu359
below 3.5 Å are described, but not those between Asp47 and
Arg233, between Leu296 and Gln300 and between Arg355
and Glu357 that also occur within the same distance (data not
shown).
A look at the distribution of the interface residues, which is
presented in Fig. 3, shows that the back interface areas of
AnaAGE and pAGE are quite different (bottom surfaces in
Figs. 3a and 3c). This is explained by the fact that the residues
involved in this interface are not conserved between AnaAGE
and pAGE (Fig. 3e). Indeed, the main interaction patch of
pAGE, which involves the loops between H4 and H5 (residues
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Table 2
Interactions at the front dimer interface for nAGE10, pAGE and
AnaAGE.
(a) nAGE10.
Hydrogen bonds vdW interactions†
1‡ 2 1 2
D48 R234 C39, D48, F52 F231
D50 R167 Y47 F231, R234, H292, P293
P108 T166 T103, L109 T166, R167
R167 D50 K107, P108 T166
R234 D48 T166 T103, K107, P108, L109
Q295 K367 R167 T103, L109
L297 Q301 F231 Y47, F52, K367
W299 L360 R234 Y47, D48
Q301 L297 Y285, Y352 L297
L360 W299 H292 Y47
K367 Q295 P293 Y47, L360, L361, N362, L363
P294, Q296 L361
Q295 L361, K367
L297 Y352, L360, L361, Y285, E298







Hydrogen bonds vdW interactions
A1 B2 A1 B2
Y49 T304 Y49 L301, C239, T304
D50 C239 D50 C239, G238, R242
R113 P171 V97, V117 L170
P114 P171, A173 T109 G172
P171 R113 R113, P114 P171, G172
A173 P114 V115 L170, A173
C239 D50 L170 K116, V97, V115, K116
R242 Y49 P171 R113, P114
C302 T371 G172 T109, R113, P114, V115
W308 A369 A173 V115
A369 W308 G238 D50
T371 C302 C239, R242 Y49, D50
L301 Y49
C302 I370, T371, I372
T308 I370
L306 Y294, Y361, E307, M310, L312
M310, L312, Y361 L306





Hydrogen bonds vdW interactions
A1 B2 A1 B2
D47 F230, R233 C38, F51 F230
D49 R166 D40, N361, L362 P292
T165 P107 Y46 F230, R233, H291, P292
R166 D49, T102 D47 F230, R233
F230 D47 T102, L108 R166
R233 D47 T165 T102, E106, P107, L108, V109
L296 Q300 R166 T102, L108, V109
W298 L359 F230 Y46, F51, K366
Q300 L296 R233 Y46, D47
R355 E357 Y284, Y351 L296
E357 R355 H291 Y46
L359 W298 P292 Y46, L360, N361, L362
P293 L360
Q294 L360, K366, W367
L296 Y284, E297, Q300, Y351, L359, L360
E297 L296, E297, Q300
W298 L359, L360
D299 L359
Q300 L296, E297, Q300
N353 R355
R355 N353, R355
L359 L296, W298, D299
L360 P292, P293, Q294, L296, W298
K366 F230, Q294
W367 Q294
† Between H atoms of monomers; within 4.5 Å. ‡ Monomers. In the cases of pAGE
and AnaAGE, the chain is specified.
Table 2 (continued)
135–140) and between H6 and H7
(residues 194–198), is missing in
AnaAGE. The shape of these
loops is thus different and the
monomers are further apart at
this location in AnaAGE than
they are in pAGE (data not
shown). On the contrary, the
residues involved in the front
interface area are mostly
conserved, with the exception of
the loop between H5 and H6
(residues 170–173; Fig. 3d). This
loop is also only resolved for
pAGE, and it is likely that the
interface parameters for the
cyanobacterial AGEs, in parti-
cular the solvation energy, may be
lower than calculated.
In addition to this, it was shown
that cysteines are involved in the
dimerization of pAGE (Taka-
hashi et al., 1988). The front
interface contains three cysteines
(residues 41, 239 and 302 of
pAGE), which is the exact
number of cysteines that were
alkylated by the treatment with
N-ethylmaleimide performed in
that study. Those cysteines lose at
least 55% of their solvent-acces-
sible area upon dimer formation,
with Cys239 and Cys302 involved
in hydrogen bonds to the neighbouring monomer (Table 2).
Their positions are identical to those in human AGE when
mapping the hAGE sequence onto the pAGE structure (data
not shown); mutation studies revealed the importance of
Cys41 for the stability of hAGE, while Cys239 and Cys302 do
not seem to play critical roles (Takahashi, Takahashi et al.,
2001; Takahashi, Takahashi, Kaneko, Ogasawara, Shindo,
Saito et al., 1999).
3.3. Dimer organization and ATP-binding site
One of the principal consequences of the front-to-front
dimer is for the ATP-binding site. To date, two hypotheses
have been put forward regarding the location of this site. One
involves the H5/H6 loop and the other involves a glycine-rich
fragment (residues 363–369 of AnaAGE) in the C-terminus
(Lee, Chien et al., 2007; Liao et al., 2012; Sola-Carvajal et al.,
2012; Takahashi et al., 2002, 2005). While the latter, which is
based on sequence similarity to the motif of NTPases, is
conserved across species, the evidence supporting the non-
conserved H5/H6 loop is built on experiments using chimeric
constructs, mutagenesis and ATP footprinting. A noncon-
served binding region would also better explain the differ-
ences in nucleotide affinities that are observed across both
species and nucleotide type (Lee, Chien et al., 2007; Sola-
Carvajal et al., 2012; Takahashi, Hori et al., 2001). This would
mean that the H5/H6 loop is involved in both dimer inter-
action and ATP binding. However, the second putative site
corresponds to part of the H11/H12 loop, which is also on the
front face of the monomer in a position opposite to that of the
H5/H6 loop. The loop points towards the centre of the barrel,
and if the H5/H6 loop does the same, which is the case for the
corresponding loop in pAGE, they might be in proximity to
each other. This opens the possibility of both proposed sites
being involved. Independently of which site is used, the
localization of the ATP-binding site at the dimer interface is
the determinant of its role in AGE activity, which may involve
the oligomeric state of the enzyme. The inability to obtain
crystals of the AGE–ATP complex either by co-crystallization
or soaking could indicate the dissociation of the dimeric form
upon ATP binding, as has been seen in different complexes
(Nayar & Bhattacharyya, 1997; Ahmed et al., 2015; Du et al.,
2014).
3.4. Active site and comparison with the AGE superfamily
The active site of nAGE10, which is presented in Fig. 4(a),
contains an ethylene glycol molecule and a buried chloride
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Figure 2
Comparison of the nAGE10 and pAGE dimers. Parts of the unit cell for pAGE (PDB entry 1fp3; green)
and nAGE10 (PDB entry 6f04; blue) are shown to illustrate the different crystal packings of these
structures. The residue ranges that are involved in the back-to-back interface of PDB entry 1fp3 and the
corresponding ranges in nAGE10 are coloured red. PDB entry 2gz6 (AnaAGE) has the same crystal
packing as PDB entry 1fp3 and was therefore omitted to avoid redundancy.
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Figure 3
Dimer-interaction interfaces of AGEs as a function of buried area. The AGE monomers are represented as a surface and are coloured grey. Residues
involved in dimer interactions, as calculated by PISA, are coloured purple (less than 30% buried), pink (less than 60% buried) and red (over 60%
buried). The residues at each side of the missing loop are indicated by arrows and labelled. (a) AnaAGE. Top, front; bottom, back. (b) nAGE10 (front).
(c) pAGE. Top, front; bottom, back. (d, e) Sequence alignment showing the interface residues using the same colour scheme as used for the surface
representations. (d) Front. Residues which are unresolved in the crystal structures are shown in italics. (e) Back.
Figure 4
Structure of the active site of nAGE10. nAGE10 is shown in a cartoon representation and is coloured in a green–blue palette from the N-terminus to the
C-terminus. Ethylene glycol (yellow) and active-site residues are shown as sticks, and waters and the chloride ion are shown as nonbonded spheres. (a)
Active site. Electron density (2Fo  Fc map) is shown around the waters, the chloride ion and the ethylene glycol molecule. Polar contacts for ethylene
glycol are coloured black and coordination of the chloride ion is shown in green. (b) Coordination geometry for the buried chloride ion. The five
coordinating atoms form a trigonal bipyramid (magenta) with the chloride at the centre of mass (magenta star).
ion. No ligand could be identified, although the enzyme was
crystallized in the presence of ManNAc. The ethylene glycol
interacts with the side chains of His373 and Arg58, as well as
the main chain of Trp368 and a water molecule. The chloride
ion is coordinated by the amine groups of His373 and the
Gly370 main chain, which are within its first coordination
sphere (3.4 Å), along with a water molecule (Carugo, 2014).
However, the geometry of this three-atom coordination seems
to be incorrect, as the chloride is completely outside the plane
formed by these atoms. By investigating nearby atoms, the
best geometry was obtained for a five-atom coordination, with
the ethylene glycol (3.7 Å) and Arg58 (3.5 Å) as the two
remaining partners (Fig. 4b). Other potential partners are the
amine group of Phe372, the Gly370 carbonyl and the  posi-
tion of His373. The latter would mean that His373 is flipped,
which has consequences for the interactions taking place
within the active site.
The structures of pAGE and AnaAGE contain only waters
within their active sites, and the active-site residues are
conserved compared with those of nAGE10 (not shown).
However, it is worth noting that for each of them there is a
water molecule at the position where the chloride ion is found
in the nAGE10 structure (water 389 in AnaAGE and water
521 in pAGE). The closest neighbour to both molecules is at
3.1 Å, and their B factors are below 3 Å2, while those of the
neighbouring water molecules range from 11.9 to 29.3 Å2.
While none of the AGEs could be co-crystallized with
ligands, several protein–ligand complex structures are avail-
able for other members of the AGE superfamily. A super-
imposition of the active sites of the cellobiose epimerase from
Rhodothermus marinus (RmCE; PDB entry 3wki) and the
isomerase YihS from Salmonella enterica (SeYihS; PDB entry
2zbl) is presented in Fig. 5 (Fujiwara et al., 2014; Itoh et al.,
2008). It shows that the ethylene glycol molecule in the active
site of nAGE10 is in proximity to the O5, C5, C6 and O6
positions of mannose, as well as the corresponding positions of
cellobiitol. This placement is consistent with the suggested
role of Arg63 of the epimerase PhGn2E as the agent that is
responsible for the protonation and deprotonation of
ManNAc (Wang et al., 2016). Indeed, the corresponding
position in AGE10 (Ar68) is only 2.9 Å from the oxygen of
ethylene glycol that mimicks O5 of mannose (Fig. 5b). The
other catalytic residue, Glu314 in PhGn2E (Glu309 in
nAGE10), is surprisingly not in the vicinity of the ligands, with
those in SeYihS (Gln320) and RmCE (Gln326) being more
than 7 Å away from the C2 atom of their respective
‘mannoses’ (data not shown). Glu251 in SeYihS (Glu243 in
nAGE10) is much closer: it is only 4.4 Å from the C2 atom.
Another interesting feature is the stacking interaction
between Trp385 of RmCE and the glucose ring of cellobiitol
(the same interaction is present with epilactose and glucosyl-
mannose in the other RmCE structures; PDB entries 3wkg
and 3wkh). This residue, which corresponds to Trp368 in
nAGE10, is strictly conserved in AGEs but its function has not
yet been investigated. Considering the position of the glucose
relative to the mannose ring, it may be involved in the
substrate-specificity differences observed by Wang et al. (2016)
when using derivatives of glucosamine substituted at C4 (just
like the glucose ring of cellobiitol is linked to C4 of the open
mannose ring).
A structural comparison of the active sites within the AGE
superfamily also reveals a putative binding site for the
N-acetyl group of GlcNAc/ManNAc in AGEs. For RmCE
(and SeYihS), the C2 position of the ‘mannose’ and the OH
that it carries interact with the side chains of Tyr124 (Tyr111),
His200 (His176) and Asn196 (Asn172). Those positions are
not conserved in nAGE10, where
they are replaced by Phe116,
Ile177 and Ala173, respectively
(Fig. 5c). This leaves a cavity that
would be large enough to
accommodate an N-acetyl group
and would also explain why
PhGn2E is not active on glucos-
amine, as it would not be retained
in the active site. All three resi-
dues are either almost or strictly
conserved in AGEs.
RmCE also possesses a
chloride ion within its active site,
at the same location as that in
nAGE10, and the coordination
by ethylene glycol seen in
nAGE10 may not reflect what
takes place in the presence of the
substrate. The structure of
another CE from Ruminococcus
albus (RaCE; PDB entry 3vw5;
Fujiwara et al., 2013) contains a
water (water 451) at the ‘chloride
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Figure 5
Comparison of active sites in the AGE family. The active sites of RmCE in complex with cellobiitol (wheat;
PDB entry 3wki) and SeYihS in complex with mannose (light pink; PDB entry 2zbl) are superimposed onto
the structure of nAGE10 (blues, with ethylene glycol in yellow). The C2 atoms of the mannose rings of
cellobiitol and mannose are indicated by black arrows. Residues of nAGE10 are labelled. (a) Overview.
Perspective was added for visualization purposes. (b) Detail of the catalytic residues and the interaction
with Trp368. (c) Detail of the N-acetyl group binding pocket.
location’, with a similar B factor to those of the neighbouring
waters. Investigating the residues corresponding to coordi-
nating residues in RmCE reveals that Gly387 is replaced by a
cysteine (Cys371) in RaCE. In yihS-encoded proteins the
spatial organization of waters differs from those in CEs and
AGEs, despite their shared fold (PDB entries 2zbl, 2afa and
2rgk; Itoh et al., 2008; SGX Research Center for Structural
Genomics, unpublished work). The coordinating glycine is
replaced in this case by an aspartate (Asp380 in SeYihS) that
is conserved within the structures. This strengthens the
hypothesis of a conserved chloride within the AGE active site
and opens the possibility of studying its role by mutating the
glycine position of AGEs.
3.5. Sequence similarity to characterized AGEs
The amino-acid sequence of nAGE10 was compared with
those of other characterized AGEs from cyanobacteria, as
well as those from human, pig, rat, B. ovatus and P. heparinus
(Klermund et al., 2013; Lee, Chien et al., 2007; Maru et al.,
1996; Sola-Carvajal et al., 2012; Tabata et al., 2002; Takahashi,
Takahashi, Kaneko, Ogasawara, Shindo, Saito & Kobayashi,
1999). Their sequences are presented in Fig. 6 as a multiple
sequence alignment, which shows that the nAGE10 sequence
is closest to that of N. punctiforme PCC 73102, with 96.14%
sequence identity (Edgar, 2004a,b). AGEs are quite conserved
amongst related species, with greater than 80% identity within
mammalian sequences and greater than 90% in the Nostoca-
ceae family (Anabaena and Nostoc genera). For the latter,
sequences from Anabaena are grouped together along with
that of Nostoc sp. PCC 7120, which is also known as Anabaena
sp. PCC 7120 (Kaneko et al., 2001). This is consistent with the
currently accepted phylogenic distribution of Nostoc and
Anabaena strains (Svenning et al., 2005). The sequences for
P. heparinus, B. ovatus and Synechocystis sp. stand out, which
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Figure 6
Sequence conservation amongst AGEs. The sequences (with accession numbers in parentheses) are from Sus scrofa (NP_999065.1), Rattus norvegicus
(NP_112357.1), Homo sapiens (NP_002901.2), P. heparinus DSM2366 (ACU05446.1), B. ovatus ATCC 8483 (EDO12673.1), Synechocystis sp. PCC 6803
(BAA18210.1), Nostoc sp. PCC 7120 (WP_010997838.1), Anabaena sp. CH1 (ABG57043.1), A. variabilis ATCC 29413 (WP_011320279.1), N. punctiforme
PCC 73101 (WP_012409471.1) and Nostoc sp. KVJ10 (NNBT01000060.1). Identical residues are shown in white on a red background and similar residues
in red. -Helices and -strands correspond to those in the structures of the AGEs from pig (top; PDB entry 1fp3) and Nostoc sp. KVJ10 (bottom). Red
circles (top) indicate residues that participate in catalysis in the AGEs from P. heparinus DSM 2366 and Anabaena sp. CH1 (Lee, Wu et al., 2007; Wang et
al., 2016). Green circles (bottom) indicate residues that coordinate the chloride ion in Nostoc sp. KVJ10. The blue frames indicate the putative ATP-
binding sites (Liao et al., 2012; Wang et al., 2016).
is expected considering that they do not belong to either of the
two aforementioned groups.
3.6. Expression and purification
The AGE from Nostoc sp. KVJ10 was successfully expressed
as a soluble, His-tagged protein in E. coli BL21 Star (DE3)
cells. It could be purified in one step by affinity chromato-
graphy, giving a yield of purified protein of up to 40 mg per
litre of culture when grown in LB medium or 87 mg per litre of
culture when using TB medium (data not shown). Gel filtra-
tion showed that nAGE10 was present as a dimer, and a
melting temperature of 72.3C was determined by DSC. The
SDS–PAGE gel and the chromatograms from the gel-filtration
and DSC experiments are presented in the supporting infor-
mation. Together with BoAGE and SynAGE, nAGE10 is the
third report of a high-yielding AGE that does not form
inclusion bodies when expressed without chaperones (Datta,
1970; Klermund et al., 2013, 2015; Lee, Chien et al., 2007; Maru
et al., 1996; Sola-Carvajal et al., 2012; Tabata et al., 2002).
3.7. Verification of nAGE10 activity
In order to verify that the purified nAGE10 was active, a
one-pot, coupled reaction with AsNAL was performed and
the production of Neu5Ac was detected by the TBA assay
(Fig. 7). The reaction was performed at 25C, according to the
optimal working conditions for the NAL. The yield from the
condensation reaction using ManNAc as a substrate (‘No
AGE’; grey bar) was defined as 100% for the purposes of
comparison with the coupled reaction. The results show that
the synthesis of Neu5Ac from GlcNAc is possible and that
40% of the maximum yield could be achieved under the assay
conditions. It is worth noting that different conditions can give
a much higher yield (data not shown). For the condensation
reaction, the presence of active AGE (i.e. with ATP) reduces
the yield starting from ManNAc by 28%, showing that
nAGE10 is active in both directions. AGE will initially speed
up the formation of GlcNAc; however, when the NAL uses
more of the ManNAc then the production of ManNAc by the
AGE will increase. The incubation times used will determine
how severe this effect is. In the absence of ATP, only a fraction
of Neu5Ac could be synthetized from GlcNAc, while the
condensation reaction was not affected.
4. Conclusion
The crystal structure of nAGE10 presents a different dimer
organization to that previously published for AGE structures,
while the monomeric unit is very similar. The dimerization
interface involves the front faces of each AGE monomer, and
analysis revealed that this assembly is the most probable dimer
association for AGEs. The front-to-front dimer organization
leaves open previous hypotheses regarding the location of the
ATP-binding site and raises the question of whether ATP
binding affects the dimer interactions at the interface. This
opens new perspectives to analyze and understand the role of
ATP in the regulation of AGE activity. Another difference
from the previously published AGE structures was the
presence of an ethylene glycol molecule and a chloride ion
within the active site of nAGE10. Comparison with the active
sites of other members of the AGE superfamily, cellobiose
2-epimerases and yihS-encoded isomerases, suggests that the
chloride ion may be a conserved element of the active site and
that ethylene glycol mimics the way that substrates of AGE
may bind. In addition to this, it was possible to formulate a
hypothesis for the binding of the N-acetyl group of hexos-
amines. nAGE10 can be used for the one-pot synthesis of sialic
acid at 25C when coupled with the NAL from the psychro-
philic bacterium A. salmonicida. The insight gained from this
structure offers new residues to consider for mutation studies.
Together, these observations open new paths of investigation
with new residues to consider, which may lead to a better
understanding of AGEs.
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Figure S1 Purification and determination of melting temperature of nAGE10. (a) One-step 
purification of nAGE10. Lane 1: insoluble fraction. Lane 2: soluble fraction. Lane 3: Flow through. 
Lane 4: Washing at 5% elution buffer. Lanes 5-8: Elution fractions. The first elution fraction (lane 5) 
represents a peak at 25% elution buffer, while the others (lanes 6-8) encompass a peak at 60% elution 
buffer. A total of 37,8 mg purified nAGE10 was harvested from those. (b) Differential scanning 
calorimetry (DSC) experiment. The thermal denaturation of nAGE10 was followed from 5 to 95°C at 
a rate of 1°C/min. The thermogram shows the transition phase between 60 and 80°C. The melting 
temperature Tm is indicated by a vertical dashed line crossing the transition peak at T=72.15°C. (c) 
Size exclusion chromatography (SEC) of native nAGE10. (d) Standard curve for the SEC experiment. 
 
 
